Signaling Pathway Analyses
Organism Code: dre
Signaling Pathway File Creation Date: 03/16/22
Pathway DB Name: REACTOME
Deduplicate Gene Sets: false
Data Source: BPA_DESeq_normData
Work Source: BPA_DESeq_normData_williams_0.05_NOMTC_foldfilter1.5_BMD
BMDExpress3 Version: BMDExpress 3.00.0020 BETA
Timestamp (Start Time): 10/24/2022 10:20.37
Remove Promiscuous Probes: true
Remove BMD > Highest Dose from Category Descriptive Statistics: true
Remove BMD with p-Value < Cutoff: 0.1
Remove genes with BMD/BMDL >: 20.0
Remove genes with BMDU/BMDL >: 40.0
Remove genes with BMDU/BMD >: 20.0
Remove genes with BMD values > N fold below the lowest positive does: 10.0
Identify conflicting probe sets: 0.5
Category Count: 555
Total Run Time: 14 seconds

GO/Pathway/Gene Set/Gene ID	GO/Pathway/Gene Set/Gene Name	All Genes (Expression Data)	All Genes (Platform)	Input Genes	Genes with BMD <= Highest Dose	Genes with BMD p-Value >= 	Genes with BMD/BMDL <= 	Genes with BMDU/BMD <= 	Genes with BMDU/BMDL <= 	Genes with BMD <= N-Fold Lowest Positive Dose 	Genes That Passed All Filters	Fisher's A Parameter	Fisher's B Parameter	Fisher's C Parameter	Fisher's D Parameter	Fisher's Exact Left P-Value	Fisher's Exact Right P-Value	Fisher's Exact Two Tail	Percentage	Entrez Gene IDs	Gene Symbols	Probe IDs	Genes with Conflicting Probesets	BMD Mean	BMD Median	BMD Minimum	BMD Standard Deviation	BMD wMean	BMD wSD	BMDL Mean	BMDL Median	BMDL Minimum	BMDL Standard Deviation	BMDL wMean	BMDL wSD	BMDU Mean	BMDU Median	BMDU Minimum	BMDU Standard Deviation	BMDU wMean	BMDU wSD	5th Percentile Index	BMD at 5th Percentile of Total Genes	10th Percentile Index	BMD at 10th Percentile of Total Genes	BMD List	BMDL List	BMDU List	Probes with Adverse Direction Up	Probes with Adverse Direction Down	Genes with Adverse Direction Up	Genes Up List	Genes Up Probes List	Genes Up BMD Mean	Genes Up BMD Median	Genes Up SD	Genes Up BMDL Mean	Genes Up BMDL Median	Genes Up BMDL SD	Genes Up BMDU Mean	Genes Up BMDU Median	Genes Up BMDU SD	BMD list (up)	BMDL List (up)	BMDU List (up)	Genes with Adverse Direction Down	Genes Down List	Genes Down Probes List	Genes Down BMD Mean	Genes Down BMD Median	Genes Down SD	Genes Down BMDL Mean	Genes Down BMDL Median	Genes Down BMDL SD	Genes Down BMDU Mean	Genes Down BMDU Median	Genes Down BMDU SD	BMD list (down)	BMDL List (down)	BMDU List (down)	Genes with Adverse Conflict Count	Genes Conflict List	Genes Conflict Probes List	BMD list (Conflict)	BMDL list (Conflict)	BMDU list (Conflict)	Model Counts	Mean Fold Change	Total Fold Change	Min Fold Change	Max Fold Change	Standard Deviation Fold Change	Median Fold Change	Lower bound of the 95% confidence interval -  BMD	Upper bound of the 95% confidence interval -  BMD	Lower bound of the 95% confidence interval -  BMDL	Upper bound of the 95% confidence interval -  BMDL	Lower bound of the 95% confidence interval -  BMDU	Upper bound of the 95% confidence interval -  BMDU	Overall Direction	Percent Genes With Overall Direction Up	Percent Genes With Overall Direction Down	Percent Genes With Overall Direction Conflict
R-DRE-109582	Hemostasis	244	307	14	12	6	8	8	8	14	2	2	15	305	4570	0.91343	0.2895	0.2895	0.65	386658;323197	ndnl2;racgap1	ENSDARG00000058212;ENSDARG00000015460		521.905	521.905	481.815	56.69582171553821	503.92768479580917	50.67591613477139	280.9915	280.9915	270.053	15.46937505201991	276.0864148824884	13.826852298333641	970.7660000000001	970.7660000000001	859.632	157.1672100407713	920.9308553778362	140.47935304868227					481.815;561.995	270.053;291.93	859.632;1081.9	2	0	2	386658;323197	ENSDARG00000058212;ENSDARG00000015460	521.905	521.905	56.69582171553821	280.9915	280.9915	15.46937505201991	970.7660000000001	970.7660000000001	157.1672100407713	481.815;561.995	270.053;291.93	859.632;1081.9	0															0						Linear,2(1)	2.533899913687352	5.297247767448425	1.8775469064712524	3.419700860977173	1.0904675188647868	2.6486238837242126	443.3286	600.4814	259.55204	302.43095999999997	752.94336	1188.5886400000002	UP	1.0	0.0	0.0	
R-DRE-114608	Platelet degranulation 	47	69	2	2	2	1	1	1	2	1	1	16	68	4807	0.97674	0.21485	0.21485	1.45	386658	ndnl2	ENSDARG00000058212		481.815	481.815	481.815		481.815		270.053	270.053	270.053		270.053		859.632	859.632	859.632		859.632						481.815	270.053	859.632	1	0	1	386658	ENSDARG00000058212	481.815	481.815		270.053	270.053		859.632	859.632		481.815	270.053	859.632	0															0						Linear,1(1)	1.8775469064712524	1.8775469064712524	1.8775469064712524	1.8775469064712524	0.0	1.8775469064712524	481.815	481.815	270.053	270.053	859.632	859.632	UP	1.0	0.0	0.0	
R-DRE-168249	Innate Immune System	380	502	13	12	4	10	10	8	13	2	2	15	500	4375	0.74969	0.5331	0.69131	0.4	558420;450039	peli1b;chga	ENSDARG00000044083;ENSDARG00000008829		348.1465	348.1465	56.431	412.5480164544486	212.1584597633703	364.9799606905858	159.89374999999998	159.89374999999998	11.6285	209.67872737863755	90.7774336483013	185.50212490176176	801.2294999999999	801.2294999999999	273.849	745.8286556311041	555.3822938898898	659.832316620068					639.862;56.431	308.159;11.6285	1328.61;273.849	0	2	0															2	558420;450039	ENSDARG00000044083;ENSDARG00000008829	348.1465	348.1465	412.5480164544486	159.89374999999998	159.89374999999998	209.67872737863755	801.2294999999999	801.2294999999999	745.8286556311041	639.862;56.431	308.159;11.6285	1328.61;273.849	0						Hill,1(0.5);Linear,1(0.5)	1.7516979457551345	3.5055038928985596	1.6919761896133423	1.8135277032852173	0.08594989958087215	1.7527519464492798	-223.6158799999999	919.90888	-130.70614000000003	450.49364	-232.4362799999999	1834.8952799999997	DOWN	0.0	1.0	0.0	
R-DRE-168256	Immune System	617	839	20	19	7	15	15	13	20	4	4	13	835	4040	0.84747	0.33121	0.51521	0.48	558420;555190;450039;100002256	peli1b;fbxo31;chga;pik3ap1	ENSDARG00000044083;ENSDARG00000062195;ENSDARG00000008829;ENSDARG00000078285		359.7365	371.3265	56.431	238.8362313532015	327.4575893502345	180.31033716584264	194.900375	229.90699999999998	11.6285	127.7178083363051	190.90547783721428	108.99226452042161	700.5284999999999	599.8275	273.849	446.706079262043	590.2481096054611	290.0039865838112					639.862;385.381;56.431;357.272	308.159;235.759;11.6285;224.055	1328.61;629.959;273.849;569.696	2	2	2	555190;100002256	ENSDARG00000062195;ENSDARG00000078285	371.3265	371.3265	19.876064512371997	229.90699999999998	229.90699999999998	8.275977767008602	599.8275	599.8275	42.612375954644016	385.381;357.272	235.759;224.055	629.959;569.696	2	558420;450039	ENSDARG00000044083;ENSDARG00000008829	348.1465	348.1465	412.5480164544486	159.89374999999998	159.89374999999998	209.67872737863755	801.2294999999999	801.2294999999999	745.8286556311041	639.862;56.431	308.159;11.6285	1328.61;273.849	0						Hill,1(0.25);Linear,3(0.75)	2.0510961867312956	8.314117431640625	1.6919761896133423	2.516936779022217	0.39041947981566805	2.052602231502533	125.67699327386251	593.7960067261374	69.73692283042098	320.063827169579	262.75654232319783	1138.3004576768021	CONFLICT	0.5	0.5	0.0	
R-DRE-6798695	Neutrophil degranulation	213	300	7	6	1	5	5	4	7	0	0	17	300	4575	0.34039	1.0	0.62064	0.0																														0	0	0															0															0																							
R-DRE-76002	Platelet activation, signaling and aggregation	109	141	7	6	4	4	4	4	7	1	1	16	140	4735	0.91539	0.39226	0.39226	0.71	386658	ndnl2	ENSDARG00000058212		481.815	481.815	481.815		481.815		270.053	270.053	270.053		270.053		859.632	859.632	859.632		859.632						481.815	270.053	859.632	1	0	1	386658	ENSDARG00000058212	481.815	481.815		270.053	270.053		859.632	859.632		481.815	270.053	859.632	0															0						Linear,1(1)	1.8775469064712524	1.8775469064712524	1.8775469064712524	1.8775469064712524	0.0	1.8775469064712524	481.815	481.815	270.053	270.053	859.632	859.632	UP	1.0	0.0	0.0	
R-DRE-76005	Response to elevated platelet cytosolic Ca2+	49	71	3	3	3	1	1	1	3	1	1	16	70	4805	0.97546	0.22038	0.22038	1.41	386658	ndnl2	ENSDARG00000058212		481.815	481.815	481.815		481.815		270.053	270.053	270.053		270.053		859.632	859.632	859.632		859.632						481.815	270.053	859.632	1	0	1	386658	ENSDARG00000058212	481.815	481.815		270.053	270.053		859.632	859.632		481.815	270.053	859.632	0															0						Linear,1(1)	1.8775469064712524	1.8775469064712524	1.8775469064712524	1.8775469064712524	0.0	1.8775469064712524	481.815	481.815	270.053	270.053	859.632	859.632	UP	1.0	0.0	0.0	
R-DRE-1430728	Metabolism	827	1029	27	19	5	20	20	18	27	4	4	13	1025	3850	0.72242	0.49423	0.76772	0.39	564852;559072;402961;394148	pfkfb2b;gba;ppa2;cyp7a1	ENSDARG00000002037;ENSDARG00000076058;ENSDARG00000009685;ENSDARG00000069018		450.90649999999994	445.61400000000003	357.267	104.83578185746845	464.55935697194326	107.26637483906443	255.97125	254.844	223.934	35.432910261271516	260.36346869064323	36.099977343606575	799.6305	783.421	569.99	258.99201785576304	834.4233016646957	265.8027900890039					357.267;555.131;527.114;364.114	223.934;290.263;282.787;226.901	569.99;1061.69;982.538;584.304	4	0	4	564852;559072;402961;394148	ENSDARG00000002037;ENSDARG00000076058;ENSDARG00000009685;ENSDARG00000069018	450.90649999999994	445.61400000000003	104.83578185746845	255.97125	254.844	35.432910261271516	799.6305	783.421	258.99201785576304	357.267;555.131;527.114;364.114	223.934;290.263;282.787;226.901	569.99;1061.69;982.538;584.304	0															0						Linear,4(1)	3.526609758693026	15.308497667312622	2.3825085163116455	6.696079254150391	1.944812035331047	3.114954948425293	348.1674337796811	553.6455662203189	221.24699794395374	290.6955020560463	545.818322501352	1053.442677498648	UP	1.0	0.0	0.0	
R-DRE-156580	Phase II - Conjugation of compounds	42	48	2	1	0	1	1	1	2	0	0	17	48	4827	0.84544	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211859	Biological oxidations	89	112	4	3	1	3	3	3	4	1	1	16	111	4764	0.94351	0.32591	0.32591	0.89	394148	cyp7a1	ENSDARG00000069018		364.114	364.114	364.114		364.114		226.901	226.901	226.901		226.901		584.304	584.304	584.304		584.304						364.114	226.901	584.304	1	0	1	394148	ENSDARG00000069018	364.114	364.114		226.901	226.901		584.304	584.304		364.114	226.901	584.304	0															0						Linear,1(1)	2.3825085163116455	2.3825085163116455	2.3825085163116455	2.3825085163116455	0.0	2.3825085163116455	364.114	364.114	226.901	226.901	584.304	584.304	UP	1.0	0.0	0.0	
R-DRE-1266738	Developmental Biology	192	204	4	3	2	2	2	2	4	0	0	17	204	4671	0.48416	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	60	73	1	1	1	0	0	0	1	0	0	17	73	4802	0.77413	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-392499	Metabolism of proteins	813	976	26	17	10	19	19	15	26	6	6	11	970	3905	0.96306	0.10433	0.12692	0.61	555190;504088;402961;394027;386658;100001665	fbxo31;enpep;ppa2;rpsa;ndnl2;otulina	ENSDARG00000062195;ENSDARG00000057064;ENSDARG00000009685;ENSDARG00000019181;ENSDARG00000058212;ENSDARG00000073931		462.6813333333334	461.4085	304.042	115.25950686631715	453.99898893430856	93.37378569834927	258.67516666666666	263.334	199.25	37.8522085295783	257.62579984532346	29.665046119976893	835.3418333333333	808.7539999999999	463.946	297.1296349207983	805.5549738304334	244.61791275862788					385.381;304.042;527.114;441.002;481.815;636.734	235.759;199.25;282.787;256.615;270.053;307.587	629.959;463.946;982.538;757.876;859.632;1318.1	6	0	6	555190;504088;402961;394027;386658;100001665	ENSDARG00000062195;ENSDARG00000057064;ENSDARG00000009685;ENSDARG00000019181;ENSDARG00000058212;ENSDARG00000073931	462.6813333333334	461.4085	115.25950686631715	258.67516666666666	263.334	37.8522085295783	835.3418333333333	808.7539999999999	297.1296349207983	385.381;304.042;527.114;441.002;481.815;636.734	235.759;199.25;282.787;256.615;270.053;307.587	629.959;463.946;982.538;757.876;859.632;1318.1	0															0						Linear,6(1)	2.0282134176655893	12.457303166389465	1.655470609664917	3.029240608215332	0.5218759894110514	1.9102040529251099	370.45451992308466	554.9081467435819	228.3870917986021	288.9632415347312	597.5886089483012	1073.0950577183658	UP	1.0	0.0	0.0	
R-DRE-525793	Myogenesis	16	17	1	0	0	1	1	1	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-597592	Post-translational protein modification	623	751	20	13	6	14	14	11	20	3	3	14	748	4127	0.74207	0.49695	0.7366	0.4	555190;386658;100001665	fbxo31;ndnl2;otulina	ENSDARG00000062195;ENSDARG00000058212;ENSDARG00000073931		501.30999999999995	481.815	385.381	126.8054569843114	462.1684320128225	121.08341448035112	271.133	270.053	235.759	35.926177030126595	259.33917355707075	35.17604181576497	935.8969999999999	859.632	629.959	350.35235355139247	831.8391710108556	329.95204548062065					385.381;481.815;636.734	235.759;270.053;307.587	629.959;859.632;1318.1	3	0	3	555190;386658;100001665	ENSDARG00000062195;ENSDARG00000058212;ENSDARG00000073931	501.30999999999995	481.815	126.8054569843114	271.133	270.053	35.926177030126595	935.8969999999999	859.632	350.35235355139247	385.381;481.815;636.734	235.759;270.053;307.587	629.959;859.632;1318.1	0															0						Linear,3(1)	2.029529229504723	6.112084865570068	1.8775469064712524	2.2916767597198486	0.22265136699395524	1.9428611993789673	357.816117139773	644.8038828602271	230.47870356057635	311.7872964394236	539.4359897571337	1332.3580102428662	UP	1.0	0.0	0.0	
R-DRE-8957275	Post-translational protein phosphorylation	54	60	1	1	1	0	0	0	1	0	0	17	60	4815	0.81047	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-109581	Apoptosis	64	71	5	5	1	4	4	4	5	0	0	17	71	4804	0.77962	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-109606	Intrinsic Pathway for Apoptosis	24	28	2	2	0	2	2	2	2	0	0	17	28	4847	0.90688	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-114452	Activation of BH3-only proteins	14	15	1	1	0	1	1	1	1	0	0	17	15	4860	0.94905	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1257604	PIP3 activates AKT signaling	125	159	3	3	2	2	2	2	3	1	1	16	158	4717	0.89615	0.4303	0.4303	0.63	100002256	pik3ap1	ENSDARG00000078285		357.272	357.272	357.272		357.272		224.055	224.055	224.055		224.05499999999998		569.696	569.696	569.696		569.696						357.272	224.055	569.696	1	0	1	100002256	ENSDARG00000078285	357.272	357.272		224.055	224.055		569.696	569.696		357.272	224.055	569.696	0															0						Linear,1(1)	2.516936779022217	2.516936779022217	2.516936779022217	2.516936779022217	0.0	2.516936779022217	357.272	357.272	224.055	224.055	569.696	569.696	UP	1.0	0.0	0.0	
R-DRE-1280215	Cytokine Signaling in Immune system	153	205	4	4	1	4	4	4	4	1	1	16	204	4671	0.84233	0.51759	0.51759	0.49	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-1280218	Adaptive Immune System	267	364	11	10	4	9	9	7	11	2	2	15	362	4513	0.87212	0.3644	0.3644	0.55	555190;100002256	fbxo31;pik3ap1	ENSDARG00000062195;ENSDARG00000078285		371.3265	371.3265	357.272	19.876064512371997	373.32829471021364	19.673423097578727	229.90699999999998	229.90699999999998	224.055	8.275977767008602	230.7405054711424	8.191602117970906	599.8275	599.8275	569.696	42.612375954644016	604.1191558618808	42.17793219713657					385.381;357.272	235.759;224.055	629.959;569.696	2	0	2	555190;100002256	ENSDARG00000062195;ENSDARG00000078285	371.3265	371.3265	19.876064512371997	229.90699999999998	229.90699999999998	8.275977767008602	599.8275	599.8275	42.612375954644016	385.381;357.272	235.759;224.055	629.959;569.696	0															0						Linear,2(1)	2.4016672380180704	4.808613538742065	2.2916767597198486	2.516936779022217	0.15928288717891712	2.4043067693710327	343.77968000000004	398.87332	218.43708	241.37691999999996	540.7697600000001	658.8852399999998	UP	1.0	0.0	0.0	
R-DRE-162582	Signal Transduction	1006	1352	26	21	8	17	17	15	26	3	3	14	1349	3526	0.26632	0.88862	0.42924	0.22	323197;100002256;100001665	racgap1;pik3ap1;otulina	ENSDARG00000015460;ENSDARG00000078285;ENSDARG00000073931		518.667	561.995	357.272	144.68150900858032	466.93158700446423	157.97119559817614	274.524	291.93	224.055	44.402988446724976	257.69903068362123	48.07248955324342	989.8986666666666	1081.9	569.696	382.5902779806791	858.6923886433774	419.07189222078244					561.995;357.272;636.734	291.93;224.055;307.587	1081.9;569.696;1318.1	3	0	3	323197;100002256;100001665	ENSDARG00000015460;ENSDARG00000078285;ENSDARG00000073931	518.667	561.995	144.68150900858032	274.524	291.93	44.402988446724976	989.8986666666666	1081.9	382.5902779806791	561.995;357.272;636.734	291.93;224.055;307.587	1081.9;569.696;1318.1	0															0						Linear,3(1)	2.557215922722651	7.879498839378357	1.9428611993789673	3.419700860977173	0.7444910056407902	2.516936779022217	354.944459981184	682.389540018816	224.27728842822052	324.7707115717795	556.9570107029681	1422.840322630365	UP	1.0	0.0	0.0	
R-DRE-1640170	Cell Cycle	315	392	12	9	5	6	6	4	12	1	1	16	391	4484	0.59954	0.75885	1.0	0.26	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-194138	Signaling by VEGF	57	62	1	1	1	0	0	0	1	0	0	17	62	4813	0.80478	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-198323	AKT phosphorylates targets in the cytosol	8	8	1	1	1	0	0	0	1	0	0	17	8	4867	0.97252	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-199418	Negative regulation of the PI3K/AKT network	47	69	1	1	1	1	1	1	1	1	1	16	68	4807	0.97674	0.21485	0.21485	1.45	100002256	pik3ap1	ENSDARG00000078285		357.272	357.272	357.272		357.272		224.055	224.055	224.055		224.05499999999998		569.696	569.696	569.696		569.696						357.272	224.055	569.696	1	0	1	100002256	ENSDARG00000078285	357.272	357.272		224.055	224.055		569.696	569.696		357.272	224.055	569.696	0															0						Linear,1(1)	2.516936779022217	2.516936779022217	2.516936779022217	2.516936779022217	0.0	2.516936779022217	357.272	357.272	224.055	224.055	569.696	569.696	UP	1.0	0.0	0.0	
R-DRE-199991	Membrane Trafficking	287	314	6	4	3	2	2	2	6	1	1	16	313	4562	0.70124	0.67686	1.0	0.32	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-212436	Generic Transcription Pathway	399	488	10	7	4	7	7	5	10	2	2	15	486	4389	0.76313	0.51718	0.68421	0.41	30445;30071	brd2a;tbx5a	ENSDARG00000022280;ENSDARG00000024894		324.427815	324.427815	9.60763	445.2229753358069	132.8782185274693	353.32846184434356	155.010175	155.010175	2.15135	216.17502344341554	62.00455578909969	171.5562600173928	685.10815	685.10815	42.9063	908.210566051092	294.36603407940646	720.754902847452					9.60763;639.248	2.15135;307.869	42.9063;1327.31	2	0	2	30445;30071	ENSDARG00000022280;ENSDARG00000024894	324.427815	324.427815	445.2229753358069	155.010175	155.010175	216.17502344341554	685.10815	685.10815	908.210566051092	9.60763;639.248	2.15135;307.869	42.9063;1327.31	0															0						Hill,1(0.5);Linear,1(0.5)	3.26946232910185	7.462456822395325	1.9332624673843384	5.529194355010986	2.542707822425745	3.7312284111976624	-292.6197476000001	941.4753776000001	-144.59312199999997	454.613472	-573.6074759999998	1943.8237759999997	UP	1.0	0.0	0.0	
R-DRE-3700989	Transcriptional Regulation by TP53	173	210	2	2	2	0	0	0	2	0	0	17	210	4665	0.47372	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-372790	Signaling by GPCR	176	374	4	4	1	2	2	2	4	0	0	17	374	4501	0.25812	1.0	0.63547	0.0																														0	0	0															0															0																							
R-DRE-388396	GPCR downstream signalling	168	360	4	4	1	2	2	2	4	0	0	17	360	4515	0.27208	1.0	0.63128	0.0																														0	0	0															0															0																							
R-DRE-388841	Costimulation by the CD28 family	27	34	1	1	0	1	1	1	1	0	0	17	34	4841	0.88802	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-392451	G beta:gamma signalling through PI3Kgamma	15	18	1	1	1	0	0	0	1	0	0	17	18	4857	0.93916	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-397795	G-protein beta:gamma signalling	18	22	1	1	1	0	0	0	1	0	0	17	22	4853	0.92612	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4420097	VEGFA-VEGFR2 Pathway	54	58	1	1	1	0	0	0	1	0	0	17	58	4817	0.8162	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-453279	Mitotic G1 phase and G1/S transition	80	94	2	1	1	1	1	1	2	0	0	17	94	4781	0.71865	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5357801	Programmed Cell Death	70	77	6	6	2	5	5	5	6	1	1	16	76	4799	0.97145	0.23674	0.23674	1.3	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-5653656	Vesicle-mediated transport	302	337	7	4	3	3	3	3	7	1	1	16	336	4539	0.67091	0.70342	1.0	0.3	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-6807070	PTEN Regulation	67	79	1	1	0	1	1	1	1	0	0	17	79	4796	0.75788	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69202	Cyclin E associated events during G1/S transition 	42	51	1	1	1	0	0	0	1	0	0	17	51	4824	0.83656	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69206	G1/S Transition	64	77	2	1	1	1	1	1	2	0	0	17	77	4798	0.76326	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69242	S Phase	85	101	1	1	1	0	0	0	1	0	0	17	101	4774	0.701	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69278	Cell Cycle, Mitotic	273	331	12	9	5	6	6	4	12	1	1	16	330	4545	0.67881	0.6967	1.0	0.3	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-69656	Cyclin A:Cdk2-associated events at S phase entry	43	52	1	1	1	0	0	0	1	0	0	17	52	4823	0.83363	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73857	RNA Polymerase II Transcription	431	524	10	7	4	7	7	5	10	2	2	15	522	4353	0.72827	0.55747	0.70271	0.38	30445;30071	brd2a;tbx5a	ENSDARG00000022280;ENSDARG00000024894		324.427815	324.427815	9.60763	445.2229753358069	132.8782185274693	353.32846184434356	155.010175	155.010175	2.15135	216.17502344341554	62.00455578909969	171.5562600173928	685.10815	685.10815	42.9063	908.210566051092	294.36603407940646	720.754902847452					9.60763;639.248	2.15135;307.869	42.9063;1327.31	2	0	2	30445;30071	ENSDARG00000022280;ENSDARG00000024894	324.427815	324.427815	445.2229753358069	155.010175	155.010175	216.17502344341554	685.10815	685.10815	908.210566051092	9.60763;639.248	2.15135;307.869	42.9063;1327.31	0															0						Hill,1(0.5);Linear,1(0.5)	3.26946232910185	7.462456822395325	1.9332624673843384	5.529194355010986	2.542707822425745	3.7312284111976624	-292.6197476000001	941.4753776000001	-144.59312199999997	454.613472	-573.6074759999998	1943.8237759999997	UP	1.0	0.0	0.0	
R-DRE-74160	Gene expression (Transcription)	488	586	11	8	5	8	8	5	11	2	2	15	584	4291	0.66658	0.62177	1.0	0.34	30445;30071	brd2a;tbx5a	ENSDARG00000022280;ENSDARG00000024894		324.427815	324.427815	9.60763	445.2229753358069	132.8782185274693	353.32846184434356	155.010175	155.010175	2.15135	216.17502344341554	62.00455578909969	171.5562600173928	685.10815	685.10815	42.9063	908.210566051092	294.36603407940646	720.754902847452					9.60763;639.248	2.15135;307.869	42.9063;1327.31	2	0	2	30445;30071	ENSDARG00000022280;ENSDARG00000024894	324.427815	324.427815	445.2229753358069	155.010175	155.010175	216.17502344341554	685.10815	685.10815	908.210566051092	9.60763;639.248	2.15135;307.869	42.9063;1327.31	0															0						Hill,1(0.5);Linear,1(0.5)	3.26946232910185	7.462456822395325	1.9332624673843384	5.529194355010986	2.542707822425745	3.7312284111976624	-292.6197476000001	941.4753776000001	-144.59312199999997	454.613472	-573.6074759999998	1943.8237759999997	UP	1.0	0.0	0.0	
R-DRE-8939211	ESR-mediated signaling	94	118	3	1	1	2	2	0	3	0	0	17	118	4757	0.65983	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9006925	Intracellular signaling by second messengers	141	175	3	3	2	2	2	2	3	1	1	16	174	4701	0.8781	0.46222	0.46222	0.57	100002256	pik3ap1	ENSDARG00000078285		357.272	357.272	357.272		357.272		224.055	224.055	224.055		224.05499999999998		569.696	569.696	569.696		569.696						357.272	224.055	569.696	1	0	1	100002256	ENSDARG00000078285	357.272	357.272		224.055	224.055		569.696	569.696		357.272	224.055	569.696	0															0						Linear,1(1)	2.516936779022217	2.516936779022217	2.516936779022217	2.516936779022217	0.0	2.516936779022217	357.272	357.272	224.055	224.055	569.696	569.696	UP	1.0	0.0	0.0	
R-DRE-9006931	Signaling by Nuclear Receptors	127	155	4	2	1	3	3	1	4	0	0	17	155	4720	0.57795	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9006934	Signaling by Receptor Tyrosine Kinases	217	254	5	5	2	2	2	2	5	0	0	17	254	4621	0.40336	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9007101	Rab regulation of trafficking	63	67	1	0	0	0	0	0	1	0	0	17	67	4808	0.79071	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9009391	Extra-nuclear estrogen signaling	37	44	1	1	1	0	0	0	1	0	0	17	44	4831	0.8574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211945	Phase I - Functionalization of compounds	47	61	2	2	1	2	2	2	2	1	1	16	60	4815	0.98156	0.19238	0.19238	1.64	394148	cyp7a1	ENSDARG00000069018		364.114	364.114	364.114		364.114		226.901	226.901	226.901		226.901		584.304	584.304	584.304		584.304						364.114	226.901	584.304	1	0	1	394148	ENSDARG00000069018	364.114	364.114		226.901	226.901		584.304	584.304		364.114	226.901	584.304	0															0						Linear,1(1)	2.3825085163116455	2.3825085163116455	2.3825085163116455	2.3825085163116455	0.0	2.3825085163116455	364.114	364.114	226.901	226.901	584.304	584.304	UP	1.0	0.0	0.0	
R-DRE-373076	Class A/1 (Rhodopsin-like receptors)	51	219	1	1	0	1	1	1	1	0	0	17	219	4656	0.45845	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-416476	G alpha (q) signalling events	58	125	2	2	1	1	1	1	2	0	0	17	125	4750	0.64355	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418594	G alpha (i) signalling events	85	166	2	2	1	1	1	1	2	0	0	17	166	4709	0.55552	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-500792	GPCR ligand binding	79	264	3	3	1	1	1	1	3	0	0	17	264	4611	0.3888	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-983168	Antigen processing: Ubiquitination & Proteasome degradation	159	193	3	3	1	2	2	2	3	1	1	16	192	4683	0.85691	0.49612	0.49612	0.52	555190	fbxo31	ENSDARG00000062195		385.381	385.381	385.381		385.381		235.759	235.759	235.759		235.759		629.959	629.959	629.959		629.959						385.381	235.759	629.959	1	0	1	555190	ENSDARG00000062195	385.381	385.381		235.759	235.759		629.959	629.959		385.381	235.759	629.959	0															0						Linear,1(1)	2.2916767597198486	2.2916767597198486	2.2916767597198486	2.2916767597198486	0.0	2.2916767597198486	385.381	385.381	235.759	235.759	629.959	629.959	UP	1.0	0.0	0.0	
R-DRE-983169	Class I MHC mediated antigen processing & presentation	179	231	4	3	1	3	3	2	4	1	1	16	230	4645	0.80979	0.56119	0.56119	0.43	555190	fbxo31	ENSDARG00000062195		385.381	385.381	385.381		385.381		235.759	235.759	235.759		235.759		629.959	629.959	629.959		629.959						385.381	235.759	629.959	1	0	1	555190	ENSDARG00000062195	385.381	385.381		235.759	235.759		629.959	629.959		385.381	235.759	629.959	0															0						Linear,1(1)	2.2916767597198486	2.2916767597198486	2.2916767597198486	2.2916767597198486	0.0	2.2916767597198486	385.381	385.381	235.759	235.759	629.959	629.959	UP	1.0	0.0	0.0	
R-DRE-1236974	ER-Phagosome pathway	10	21	1	0	0	1	1	0	1	0	0	17	21	4854	0.92937	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1236975	Antigen processing-Cross presentation	42	65	1	0	0	1	1	0	1	0	0	17	65	4810	0.79631	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1236977	Endosomal/Vacuolar pathway	4	12	1	0	0	1	1	0	1	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-382551	Transport of small molecules	303	372	16	8	2	12	12	10	16	1	1	16	371	4504	0.62523	0.73993	1.0	0.27	114421	angptl3	ENSDARG00000044365		400.684	400.684	400.684		400.684		241.829	241.829	241.829		241.82899999999998		663.889	663.889	663.889		663.889						400.684	241.829	663.889	1	0	1	114421	ENSDARG00000044365	400.684	400.684		241.829	241.829		663.889	663.889		400.684	241.829	663.889	0															0						Linear,1(1)	1.5623180866241455	1.5623180866241455	1.5623180866241455	1.5623180866241455	0.0	1.5623180866241455	400.684	400.684	241.829	241.829	663.889	663.889	UP	1.0	0.0	0.0	
R-DRE-917937	Iron uptake and transport	34	45	1	0	0	1	1	0	1	0	0	17	45	4830	0.8544	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-917977	Transferrin endocytosis and recycling	18	27	1	0	0	1	1	0	1	0	0	17	27	4848	0.91006	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	12	23	1	0	0	1	1	0	1	0	0	17	23	4852	0.92289	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5673001	RAF/MAP kinase cascade	130	157	2	1	0	2	2	2	2	0	0	17	157	4718	0.57381	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5683057	MAPK family signaling cascades	151	180	2	1	0	2	2	2	2	0	0	17	180	4695	0.52815	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5684996	MAPK1/MAPK3 signaling	133	161	2	1	0	2	2	2	2	0	0	17	161	4714	0.56561	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	45	67	1	1	1	1	1	1	1	1	1	16	66	4809	0.97799	0.20929	0.20929	1.49	100002256	pik3ap1	ENSDARG00000078285		357.272	357.272	357.272		357.272		224.055	224.055	224.055		224.05499999999998		569.696	569.696	569.696		569.696						357.272	224.055	569.696	1	0	1	100002256	ENSDARG00000078285	357.272	357.272		224.055	224.055		569.696	569.696		357.272	224.055	569.696	0															0						Linear,1(1)	2.516936779022217	2.516936779022217	2.516936779022217	2.516936779022217	0.0	2.516936779022217	357.272	357.272	224.055	224.055	569.696	569.696	UP	1.0	0.0	0.0	
R-DRE-141424	Amplification of signal from the kinetochores	49	61	1	1	0	0	0	0	1	0	0	17	61	4814	0.80762	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	49	61	1	1	0	0	0	0	1	0	0	17	61	4814	0.80762	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-194315	Signaling by Rho GTPases	346	394	8	6	3	3	3	2	8	1	1	16	393	4482	0.597	0.76067	1.0	0.25	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-195258	RHO GTPase Effectors	149	179	4	3	1	1	1	0	4	0	0	17	179	4696	0.53006	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2467813	Separation of Sister Chromatids	108	129	3	3	1	0	0	0	3	0	0	17	129	4746	0.63441	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2500257	Resolution of Sister Chromatid Cohesion	65	78	3	3	1	0	0	0	3	0	0	17	78	4797	0.76057	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2555396	Mitotic Metaphase and Anaphase	134	156	4	4	2	1	1	0	4	0	0	17	156	4719	0.57588	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5663220	RHO GTPases Activate Formins	67	79	2	2	0	0	0	0	2	0	0	17	79	4796	0.75788	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68877	Mitotic Prometaphase	95	119	5	5	2	2	2	2	5	1	1	16	118	4757	0.93709	0.34252	0.34252	0.84	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-68882	Mitotic Anaphase	133	155	4	4	2	1	1	0	4	0	0	17	155	4720	0.57795	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68886	M Phase	210	252	9	8	4	5	5	3	9	1	1	16	251	4624	0.78278	0.59367	0.59367	0.4	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-69618	Mitotic Spindle Checkpoint	61	75	1	1	0	0	0	0	1	0	0	17	75	4800	0.76868	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69620	Cell Cycle Checkpoints	148	187	4	2	1	2	2	1	4	0	0	17	187	4688	0.51495	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9648025	EML4 and NUDC in mitotic spindle formation	56	69	3	3	1	0	0	0	3	0	0	17	69	4806	0.78515	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9716542	Signaling by Rho GTPases, Miro GTPases and RHOBTB3	353	403	8	6	3	3	3	2	8	1	1	16	402	4473	0.58558	0.76869	1.0	0.25	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-1632852	Macroautophagy	75	85	2	2	1	0	0	0	2	0	0	17	85	4790	0.74195	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9612973	Autophagy	75	85	2	2	1	0	0	0	2	0	0	17	85	4790	0.74195	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-156827	L13a-mediated translational silencing of Ceruloplasmin expression	76	76	2	1	1	2	2	1	2	1	1	16	75	4800	0.97214	0.23403	0.23403	1.32	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-1799339	SRP-dependent cotranslational protein targeting to membrane	64	64	2	1	1	2	2	1	2	1	1	16	63	4812	0.97981	0.20088	0.20088	1.56	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	111	118	3	1	1	2	2	1	3	1	1	16	117	4758	0.93802	0.34017	0.34017	0.85	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-72312	rRNA processing	111	118	3	1	1	2	2	1	3	1	1	16	117	4758	0.93802	0.34017	0.34017	0.85	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-72613	Eukaryotic Translation Initiation	79	79	2	1	1	2	2	1	2	1	1	16	78	4797	0.97006	0.24212	0.24212	1.27	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-72649	Translation initiation complex formation	42	42	2	1	1	2	2	1	2	1	1	16	41	4834	0.99098	0.13655	0.13655	2.38	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	42	42	2	1	1	2	2	1	2	1	1	16	41	4834	0.99098	0.13655	0.13655	2.38	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-72689	Formation of a pool of free 40S subunits	71	71	2	1	1	2	2	1	2	1	1	16	70	4805	0.97546	0.22038	0.22038	1.41	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-72695	Formation of the ternary complex, and subsequently, the 43S complex	39	39	2	1	1	2	2	1	2	1	1	16	38	4837	0.99219	0.12741	0.12741	2.56	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-72702	Ribosomal scanning and start codon recognition	41	41	2	1	1	2	2	1	2	1	1	16	40	4835	0.99139	0.13352	0.13352	2.44	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	75	75	2	1	1	2	2	1	2	1	1	16	74	4801	0.97282	0.23132	0.23132	1.33	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-72737	Cap-dependent Translation Initiation	79	79	2	1	1	2	2	1	2	1	1	16	78	4797	0.97006	0.24212	0.24212	1.27	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-72766	Translation	133	145	4	2	2	4	4	3	4	2	2	15	143	4732	0.98722	0.088774	0.088774	1.38	402961;394027	ppa2;rpsa	ENSDARG00000009685;ENSDARG00000019181		484.058	484.058	441.002	60.89037914153607	467.8959329605482	56.43769529334529	269.701	269.701	256.615	18.506398677213035	264.7888667484609	17.153095517668472	870.207	870.207	757.876	158.86002367493134	828.0409568792116	147.24318910249062					527.114;441.002	282.787;256.615	982.538;757.876	2	0	2	402961;394027	ENSDARG00000009685;ENSDARG00000019181	484.058	484.058	60.89037914153607	269.701	269.701	18.506398677213035	870.207	870.207	158.86002367493134	527.114;441.002	282.787;256.615	982.538;757.876	0															0						Linear,2(1)	2.242782977880038	4.68974769115448	1.660507082939148	3.029240608215332	0.9678407573601585	2.34487384557724	399.66823999999997	568.44776	244.05244000000005	295.34956	650.03824	1090.37576	UP	1.0	0.0	0.0	
R-DRE-8868773	rRNA processing in the nucleus and cytosol	111	118	3	1	1	2	2	1	3	1	1	16	117	4758	0.93802	0.34017	0.34017	0.85	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-8953854	Metabolism of RNA	332	372	9	6	4	4	4	2	9	1	1	16	371	4504	0.62523	0.73993	1.0	0.27	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-927802	Nonsense-Mediated Decay (NMD)	76	77	4	3	1	3	3	2	4	1	1	16	76	4799	0.97145	0.23674	0.23674	1.3	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	62	63	2	1	1	2	2	1	2	1	1	16	62	4813	0.9804	0.19805	0.19805	1.59	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	76	77	4	3	1	3	3	2	4	1	1	16	76	4799	0.97145	0.23674	0.23674	1.3	394027	rpsa	ENSDARG00000019181		441.002	441.002	441.002		441.002		256.615	256.615	256.615		256.615		757.876	757.876	757.876		757.876						441.002	256.615	757.876	1	0	1	394027	ENSDARG00000019181	441.002	441.002		256.615	256.615		757.876	757.876		441.002	256.615	757.876	0															0						Linear,1(1)	1.660507082939148	1.660507082939148	1.660507082939148	1.660507082939148	0.0	1.660507082939148	441.002	441.002	256.615	256.615	757.876	757.876	UP	1.0	0.0	0.0	
R-DRE-446203	Asparagine N-linked glycosylation	140	160	2	2	1	0	0	0	2	0	0	17	160	4715	0.56765	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-948021	Transport to the Golgi and subsequent modification	94	104	2	2	1	0	0	0	2	0	0	17	104	4771	0.69357	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-199977	ER to Golgi Anterograde Transport	76	82	2	2	1	0	0	0	2	0	0	17	82	4793	0.74988	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-196854	Metabolism of vitamins and cofactors	68	90	3	2	0	1	1	0	3	0	0	17	90	4785	0.72892	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6806667	Metabolism of fat-soluble vitamins	16	19	1	1	0	0	0	0	1	0	0	17	19	4856	0.93588	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9012999	RHO GTPase cycle	229	252	4	3	2	2	2	2	4	1	1	16	251	4624	0.78278	0.59367	0.59367	0.4	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-9696264	RND3 GTPase cycle	27	28	1	1	0	1	1	1	1	0	0	17	28	4847	0.90688	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9696270	RND2 GTPase cycle	25	27	1	1	0	1	1	1	1	0	0	17	27	4848	0.91006	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1630316	Glycosaminoglycan metabolism	58	78	2	1	0	1	1	1	2	0	0	17	78	4797	0.76057	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-71387	Metabolism of carbohydrates	120	148	7	4	1	5	5	5	7	1	1	16	147	4728	0.90806	0.40733	0.40733	0.68	564852	pfkfb2b	ENSDARG00000002037		357.267	357.267	357.267		357.267		223.934	223.934	223.934		223.93399999999997		569.99	569.99	569.99		569.99						357.267	223.934	569.99	1	0	1	564852	ENSDARG00000002037	357.267	357.267		223.934	223.934		569.99	569.99		357.267	223.934	569.99	0															0						Linear,1(1)	3.200669288635254	3.200669288635254	3.200669288635254	3.200669288635254	0.0	3.200669288635254	357.267	357.267	223.934	223.934	569.99	569.99	UP	1.0	0.0	0.0	
R-DRE-166016	Toll Like Receptor 4 (TLR4) Cascade	42	49	2	2	1	2	2	2	2	1	1	16	48	4827	0.98785	0.15753	0.15753	2.04	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-166058	MyD88:MAL(TIRAP) cascade initiated on plasma membrane	42	46	2	2	1	2	2	2	2	1	1	16	45	4830	0.98925	0.1486	0.1486	2.17	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-166166	MyD88-independent TLR4 cascade 	39	45	1	1	0	1	1	1	1	0	0	17	45	4830	0.8544	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-166520	Signaling by NTRKs	48	49	2	2	0	1	1	1	2	0	0	17	49	4826	0.84247	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168138	Toll Like Receptor 9 (TLR9) Cascade	44	49	2	2	1	2	2	2	2	1	1	16	48	4827	0.98785	0.15753	0.15753	2.04	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-168142	Toll Like Receptor 10 (TLR10) Cascade	42	46	2	2	1	2	2	2	2	1	1	16	45	4830	0.98925	0.1486	0.1486	2.17	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-168164	Toll Like Receptor 3 (TLR3) Cascade	39	45	1	1	0	1	1	1	1	0	0	17	45	4830	0.8544	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168176	Toll Like Receptor 5 (TLR5) Cascade	42	46	2	2	1	2	2	2	2	1	1	16	45	4830	0.98925	0.1486	0.1486	2.17	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-168179	Toll Like Receptor TLR1:TLR2 Cascade	42	46	2	2	1	2	2	2	2	1	1	16	45	4830	0.98925	0.1486	0.1486	2.17	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	42	47	2	2	1	2	2	2	2	1	1	16	46	4829	0.98879	0.15159	0.15159	2.13	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-168188	Toll Like Receptor TLR6:TLR2 Cascade	42	46	2	2	1	2	2	2	2	1	1	16	45	4830	0.98925	0.1486	0.1486	2.17	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-168898	Toll-like Receptor Cascades	50	60	3	3	1	3	3	3	3	1	1	16	59	4816	0.98212	0.18953	0.18953	1.67	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-181438	Toll Like Receptor 2 (TLR2) Cascade	42	46	2	2	1	2	2	2	2	1	1	16	45	4830	0.98925	0.1486	0.1486	2.17	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-187037	Signaling by NTRK1 (TRKA)	42	43	2	2	0	1	1	1	2	0	0	17	43	4832	0.86042	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-198725	Nuclear Events (kinase and transcription factor activation)	17	18	1	1	0	0	0	0	1	0	0	17	18	4857	0.93916	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-448424	Interleukin-17 signaling	31	33	1	1	0	1	1	1	1	0	0	17	33	4842	0.89114	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-449147	Signaling by Interleukins	91	122	3	3	1	3	3	3	3	1	1	16	121	4754	0.93426	0.34952	0.34952	0.82	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-450282	MAPK targets/ Nuclear events mediated by MAP kinases	18	18	1	1	0	1	1	1	1	0	0	17	18	4857	0.93916	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-450294	MAP kinase activation	31	33	1	1	0	1	1	1	1	0	0	17	33	4842	0.89114	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-937061	TRIF(TICAM1)-mediated TLR4 signaling 	39	45	1	1	0	1	1	1	1	0	0	17	45	4830	0.8544	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	42	46	2	2	1	2	2	2	2	1	1	16	45	4830	0.98925	0.1486	0.1486	2.17	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-975155	MyD88 dependent cascade initiated on endosome	42	47	2	2	1	2	2	2	2	1	1	16	46	4829	0.98879	0.15159	0.15159	2.13	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-975871	MyD88 cascade initiated on plasma membrane	42	46	2	2	1	2	2	2	2	1	1	16	45	4830	0.98925	0.1486	0.1486	2.17	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-3214841	PKMTs methylate histone lysines	26	33	2	1	1	0	0	0	2	0	0	17	33	4842	0.89114	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3247509	Chromatin modifying enzymes	84	100	3	1	1	1	1	0	3	0	0	17	100	4775	0.7035	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4839726	Chromatin organization	84	100	3	1	1	1	1	0	3	0	0	17	100	4775	0.7035	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693532	DNA Double-Strand Break Repair	64	90	2	1	0	2	2	1	2	0	0	17	90	4785	0.72892	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693538	Homology Directed Repair	50	74	1	0	0	1	1	0	1	0	0	17	74	4801	0.7714	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	36	42	2	1	0	2	2	1	2	0	0	17	42	4833	0.86345	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693567	HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	46	69	1	0	0	1	1	0	1	0	0	17	69	4806	0.78515	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693571	Nonhomologous End-Joining (NHEJ)	27	34	1	0	0	1	1	0	1	0	0	17	34	4841	0.88802	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693606	DNA Double Strand Break Response	36	42	2	1	0	2	2	1	2	0	0	17	42	4833	0.86345	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693607	Processing of DNA double-strand break ends	35	50	1	0	0	1	1	0	1	0	0	17	50	4825	0.83951	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69473	G2/M DNA damage checkpoint	42	57	1	0	0	1	1	0	1	0	0	17	57	4818	0.81908	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69481	G2/M Checkpoints	83	107	2	0	0	2	2	1	2	0	0	17	107	4768	0.6862	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73894	DNA Repair	133	177	2	1	0	2	2	1	2	0	0	17	177	4698	0.53391	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8981607	Intracellular oxygen transport	2	2	1	0	0	0	0	0	1	0	0	17	2	4873	0.99306	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-422475	Axon guidance	140	145	2	2	1	1	1	1	2	0	0	17	145	4730	0.59908	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69231	Cyclin D associated events in G1	27	32	1	1	1	0	0	0	1	0	0	17	32	4843	0.89427	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69236	G1 Phase	27	32	1	1	1	0	0	0	1	0	0	17	32	4843	0.89427	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8878171	Transcriptional regulation by RUNX1	108	134	3	1	0	2	2	1	3	0	0	17	134	4741	0.62317	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9675108	Nervous system development	141	146	2	2	1	1	1	1	2	0	0	17	146	4729	0.59694	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-112315	Transmission across Chemical Synapses	107	133	5	5	4	1	1	1	5	0	0	17	133	4742	0.6254	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-112316	Neuronal System	158	208	5	5	4	1	1	1	5	0	0	17	208	4667	0.47718	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-71291	Metabolism of amino acids and derivatives	127	156	2	2	0	2	2	2	2	0	0	17	156	4719	0.57588	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-191859	snRNP Assembly	22	26	1	1	1	1	1	0	1	0	0	17	26	4849	0.91325	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-194441	Metabolism of non-coding RNA	22	26	1	1	1	1	1	0	1	0	0	17	26	4849	0.91325	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-556833	Metabolism of lipids	269	343	7	6	2	6	6	5	7	2	2	15	341	4534	0.88813	0.33697	0.33697	0.58	559072;394148	gba;cyp7a1	ENSDARG00000076058;ENSDARG00000069018		459.62249999999995	459.62249999999995	364.114	135.06941602191085	496.7302835584507	124.45791233689533	258.582	258.582	226.901	44.80369986954204	270.89097449876476	41.28377181868815	822.9970000000001	822.9970000000001	584.304	337.56287784352094	915.736056533369	311.0428126232806					555.131;364.114	290.263;226.901	1061.69;584.304	2	0	2	559072;394148	ENSDARG00000076058;ENSDARG00000069018	459.62249999999995	459.62249999999995	135.06941602191085	258.582	258.582	44.80369986954204	822.9970000000001	822.9970000000001	337.56287784352094	555.131;364.114	290.263;226.901	1061.69;584.304	0															0						Linear,2(1)	3.9941789956023546	9.078587770462036	2.3825085163116455	6.696079254150391	3.050155119853636	4.539293885231018	272.42584	646.8191599999999	196.48724000000004	320.67675999999994	355.1587200000001	1290.83528	UP	1.0	0.0	0.0	
R-DRE-8978868	Fatty acid metabolism	74	94	2	1	0	2	2	1	2	0	0	17	94	4781	0.71865	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	12	28	3	3	1	3	3	2	3	0	0	17	28	4847	0.90688	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1679131	Trafficking and processing of endosomal TLR	4	5	1	1	0	1	1	1	1	0	0	17	5	4870	0.98274	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2022377	Metabolism of Angiotensinogen to Angiotensins	9	13	1	1	1	1	1	1	1	1	1	16	12	4863	0.99913	0.044299	0.044299	7.69	504088	enpep	ENSDARG00000057064		304.042	304.042	304.042		304.042		199.25	199.25	199.25		199.25		463.946	463.946	463.946		463.946		0.0	304.042			304.042	199.25	463.946	1	0	1	504088	ENSDARG00000057064	304.042	304.042		199.25	199.25		463.946	463.946		304.042	199.25	463.946	0															0						Linear,1(1)	1.655470609664917	1.655470609664917	1.655470609664917	1.655470609664917	0.0	1.655470609664917	304.042	304.042	199.25	199.25	463.946	463.946	UP	1.0	0.0	0.0	
R-DRE-2980736	Peptide hormone metabolism	25	40	1	1	1	1	1	1	1	1	1	16	39	4836	0.9918	0.13047	0.13047	2.5	504088	enpep	ENSDARG00000057064		304.042	304.042	304.042		304.042		199.25	199.25	199.25		199.25		463.946	463.946	463.946		463.946						304.042	199.25	463.946	1	0	1	504088	ENSDARG00000057064	304.042	304.042		199.25	199.25		463.946	463.946		304.042	199.25	463.946	0															0						Linear,1(1)	1.655470609664917	1.655470609664917	1.655470609664917	1.655470609664917	0.0	1.655470609664917	304.042	304.042	199.25	199.25	463.946	463.946	UP	1.0	0.0	0.0	
R-DRE-1428517	The citric acid (TCA) cycle and respiratory electron transport	104	119	3	1	0	2	2	2	3	0	0	17	119	4756	0.65748	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	69	81	2	0	0	1	1	1	2	0	0	17	81	4794	0.75254	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2262752	Cellular responses to stress	291	336	9	8	4	5	5	3	9	0	0	17	336	4539	0.29769	1.0	0.62546	0.0																														0	0	0															0															0																							
R-DRE-611105	Respiratory electron transport	53	64	1	0	0	0	0	0	1	0	0	17	64	4811	0.79912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8953897	Cellular responses to stimuli	291	336	9	8	4	5	5	3	9	0	0	17	336	4539	0.29769	1.0	0.62546	0.0																														0	0	0															0															0																							
R-DRE-9013148	CDC42 GTPase cycle	80	85	3	2	1	2	2	2	3	1	1	16	84	4791	0.96573	0.25805	0.25805	1.18	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-9013149	RAC1 GTPase cycle	82	91	3	2	1	2	2	2	3	1	1	16	90	4785	0.96117	0.27366	0.27366	1.1	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-9013404	RAC2 GTPase cycle	36	39	2	2	1	2	2	2	2	1	1	16	38	4837	0.99219	0.12741	0.12741	2.56	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-9013423	RAC3 GTPase cycle	45	51	2	2	1	2	2	2	2	1	1	16	50	4825	0.98689	0.16344	0.16344	1.96	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-983231	Factors involved in megakaryocyte development and platelet production	71	82	4	3	2	2	2	2	4	1	1	16	81	4794	0.96793	0.25012	0.25012	1.22	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-1474228	Degradation of the extracellular matrix	36	59	1	1	1	0	0	0	1	0	0	17	59	4816	0.81333	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1474244	Extracellular matrix organization	101	129	3	3	3	1	1	0	3	0	0	17	129	4746	0.63441	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-446652	Interleukin-1 family signaling	32	41	2	2	1	2	2	2	2	1	1	16	40	4835	0.99139	0.13352	0.13352	2.44	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-6803157	Antimicrobial peptides	12	27	2	2	1	1	1	1	2	1	1	16	26	4849	0.99621	0.089937	0.089937	3.7	450039	chga	ENSDARG00000008829		56.431	56.431	56.431		56.431		11.6285	11.6285	11.6285		11.6285		273.849	273.849	273.849		273.849						56.431	11.6285	273.849	0	1	0															1	450039	ENSDARG00000008829	56.431	56.431		11.6285	11.6285		273.849	273.849		56.431	11.6285	273.849	0						Hill,1(1)	1.8135277032852173	1.8135277032852173	1.8135277032852173	1.8135277032852173	0.0	1.8135277032852173	56.431	56.431	11.6285	11.6285	273.849	273.849	DOWN	0.0	1.0	0.0	
R-DRE-6799198	Complex I biogenesis	31	35	1	0	0	0	0	0	1	0	0	17	35	4840	0.88491	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-111471	Apoptotic factor-mediated response	8	10	1	1	0	1	1	1	1	0	0	17	10	4865	0.96576	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5218859	Regulated Necrosis	16	21	2	2	1	2	2	2	2	1	1	16	20	4855	0.9977	0.070635	0.070635	4.76	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-9663891	Selective autophagy	39	46	2	2	1	0	0	0	2	0	0	17	46	4829	0.8514	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8852135	Protein ubiquitination	43	48	1	1	1	1	1	1	1	1	1	16	47	4828	0.98833	0.15456	0.15456	2.08	100001665	otulina	ENSDARG00000073931		636.734	636.734	636.734		636.734		307.587	307.587	307.587		307.587		1318.1	1318.1	1318.1		1318.1						636.734	307.587	1318.1	1	0	1	100001665	ENSDARG00000073931	636.734	636.734		307.587	307.587		1318.1	1318.1		636.734	307.587	1318.1	0															0						Linear,1(1)	1.9428611993789673	1.9428611993789673	1.9428611993789673	1.9428611993789673	0.0	1.9428611993789673	636.734	636.734	307.587	307.587	1318.1	1318.1	UP	1.0	0.0	0.0	
R-DRE-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	22	24	1	1	1	1	1	1	1	1	1	16	23	4852	0.997	0.080333	0.080333	4.17	100001665	otulina	ENSDARG00000073931		636.734	636.734	636.734		636.734		307.587	307.587	307.587		307.587		1318.1	1318.1	1318.1		1318.1						636.734	307.587	1318.1	1	0	1	100001665	ENSDARG00000073931	636.734	636.734		307.587	307.587		1318.1	1318.1		636.734	307.587	1318.1	0															0						Linear,1(1)	1.9428611993789673	1.9428611993789673	1.9428611993789673	1.9428611993789673	0.0	1.9428611993789673	636.734	636.734	307.587	307.587	1318.1	1318.1	UP	1.0	0.0	0.0	
R-DRE-5688426	Deubiquitination	132	156	2	0	0	2	2	1	2	0	0	17	156	4719	0.57588	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5689880	Ub-specific processing proteases	102	119	1	0	0	1	1	0	1	0	0	17	119	4756	0.65748	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-111885	Opioid Signalling	44	49	1	1	1	0	0	0	1	0	0	17	49	4826	0.84247	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-112314	Neurotransmitter receptors and postsynaptic signal transmission	64	81	3	3	3	0	0	0	3	0	0	17	81	4794	0.75254	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-163685	Integration of energy metabolism	44	52	2	2	1	1	1	1	2	0	0	17	52	4823	0.83363	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-195721	Signaling by WNT	166	199	4	3	2	2	2	1	4	0	0	17	199	4676	0.49303	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3858494	Beta-catenin independent WNT signaling	83	92	2	2	2	0	0	0	2	0	0	17	92	4783	0.72377	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4086398	Ca2+ pathway	27	29	1	1	1	0	0	0	1	0	0	17	29	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418217	G beta:gamma signalling through PLC beta	12	14	1	1	1	0	0	0	1	0	0	17	14	4861	0.95237	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-422356	Regulation of insulin secretion	35	41	2	2	1	1	1	1	2	0	0	17	41	4834	0.86648	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-451326	Activation of kainate receptors upon glutamate binding	16	18	1	1	1	0	0	0	1	0	0	17	18	4857	0.93916	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-500657	Presynaptic function of Kainate receptors	13	15	1	1	1	0	0	0	1	0	0	17	15	4860	0.94905	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1483257	Phospholipid metabolism	92	108	1	1	0	0	0	0	1	0	0	17	108	4767	0.68377	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418555	G alpha (s) signalling events	36	102	2	2	1	0	0	0	2	0	0	17	102	4773	0.69852	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5357905	Regulation of TNFR1 signaling	22	27	1	1	1	1	1	1	1	1	1	16	26	4849	0.99621	0.089937	0.089937	3.7	100001665	otulina	ENSDARG00000073931		636.734	636.734	636.734		636.734		307.587	307.587	307.587		307.587		1318.1	1318.1	1318.1		1318.1						636.734	307.587	1318.1	1	0	1	100001665	ENSDARG00000073931	636.734	636.734		307.587	307.587		1318.1	1318.1		636.734	307.587	1318.1	0															0						Linear,1(1)	1.9428611993789673	1.9428611993789673	1.9428611993789673	1.9428611993789673	0.0	1.9428611993789673	636.734	636.734	307.587	307.587	1318.1	1318.1	UP	1.0	0.0	0.0	
R-DRE-73887	Death Receptor Signalling	64	78	3	3	1	3	3	3	3	1	1	16	77	4798	0.97076	0.23943	0.23943	1.28	100001665	otulina	ENSDARG00000073931		636.734	636.734	636.734		636.734		307.587	307.587	307.587		307.587		1318.1	1318.1	1318.1		1318.1						636.734	307.587	1318.1	1	0	1	100001665	ENSDARG00000073931	636.734	636.734		307.587	307.587		1318.1	1318.1		636.734	307.587	1318.1	0															0						Linear,1(1)	1.9428611993789673	1.9428611993789673	1.9428611993789673	1.9428611993789673	0.0	1.9428611993789673	636.734	636.734	307.587	307.587	1318.1	1318.1	UP	1.0	0.0	0.0	
R-DRE-75893	TNF signaling	26	31	1	1	1	1	1	1	1	1	1	16	30	4845	0.99502	0.10259	0.10259	3.23	100001665	otulina	ENSDARG00000073931		636.734	636.734	636.734		636.734		307.587	307.587	307.587		307.587		1318.1	1318.1	1318.1		1318.1						636.734	307.587	1318.1	1	0	1	100001665	ENSDARG00000073931	636.734	636.734		307.587	307.587		1318.1	1318.1		636.734	307.587	1318.1	0															0						Linear,1(1)	1.9428611993789673	1.9428611993789673	1.9428611993789673	1.9428611993789673	0.0	1.9428611993789673	636.734	636.734	307.587	307.587	1318.1	1318.1	UP	1.0	0.0	0.0	
R-DRE-71336	Pentose phosphate pathway	8	9	1	1	0	0	0	0	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1296071	Potassium Channels	37	65	1	1	1	0	0	0	1	0	0	17	65	4810	0.79631	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3371453	Regulation of HSF1-mediated heat shock response	42	45	1	1	1	1	1	0	1	0	0	17	45	4830	0.8544	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3371556	Cellular response to heat stress	56	60	1	1	1	1	1	0	1	0	0	17	60	4815	0.81047	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-196849	Metabolism of water-soluble vitamins and cofactors	47	64	2	1	0	1	1	0	2	0	0	17	64	4811	0.79912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-382556	ABC-family proteins mediated transport	57	65	2	1	0	2	2	2	2	0	0	17	65	4810	0.79631	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5173105	O-linked glycosylation	40	52	1	1	0	1	1	1	1	0	0	17	52	4823	0.83363	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2682334	EPH-Ephrin signaling	53	53	1	1	1	0	0	0	1	0	0	17	53	4822	0.8307	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3928662	EPHB-mediated forward signaling	29	29	1	1	1	0	0	0	1	0	0	17	29	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5218921	VEGFR2 mediated cell proliferation	11	11	1	1	1	0	0	0	1	0	0	17	11	4864	0.96239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9020702	Interleukin-1 signaling	23	28	1	1	1	1	1	1	1	1	1	16	27	4848	0.99593	0.093117	0.093117	3.57	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61						639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	89	100	4	3	2	2	2	2	4	1	1	16	99	4776	0.95391	0.2965	0.2965	1.0	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-112310	Neurotransmitter release cycle	32	41	1	1	0	1	1	1	1	0	0	17	41	4834	0.86648	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-352230	Amino acid transport across the plasma membrane	20	29	2	1	0	2	2	2	2	0	0	17	29	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-425366	Transport of bile salts and organic acids, metal ions and amine compounds	24	39	2	1	0	2	2	2	2	0	0	17	39	4836	0.87259	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	45	62	2	1	0	2	2	2	2	0	0	17	62	4813	0.80478	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-425407	SLC-mediated transmembrane transport	87	121	3	1	0	2	2	2	3	0	0	17	121	4754	0.65281	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-442660	Na+/Cl- dependent neurotransmitter transporters	7	14	2	1	0	2	2	2	2	0	0	17	14	4861	0.95237	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-71288	Creatine metabolism	7	13	1	1	0	1	1	1	1	0	0	17	13	4862	0.9557	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-888590	GABA synthesis, release, reuptake and degradation	14	21	1	1	0	1	1	1	1	0	0	17	21	4854	0.92937	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-888593	Reuptake of GABA	3	9	1	1	0	1	1	1	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	9	13	2	2	1	2	2	2	2	1	1	16	12	4863	0.99913	0.044299	0.044299	7.69	100002256	pik3ap1	ENSDARG00000078285		357.272	357.272	357.272		357.272		224.055	224.055	224.055		224.05499999999998		569.696	569.696	569.696		569.696		0.0	357.272			357.272	224.055	569.696	1	0	1	100002256	ENSDARG00000078285	357.272	357.272		224.055	224.055		569.696	569.696		357.272	224.055	569.696	0															0						Linear,1(1)	2.516936779022217	2.516936779022217	2.516936779022217	2.516936779022217	0.0	2.516936779022217	357.272	357.272	224.055	224.055	569.696	569.696	UP	1.0	0.0	0.0	
R-DRE-983705	Signaling by the B Cell Receptor (BCR)	50	59	3	3	2	2	2	2	3	1	1	16	58	4817	0.98269	0.18667	0.18667	1.69	100002256	pik3ap1	ENSDARG00000078285		357.272	357.272	357.272		357.272		224.055	224.055	224.055		224.05499999999998		569.696	569.696	569.696		569.696						357.272	224.055	569.696	1	0	1	100002256	ENSDARG00000078285	357.272	357.272		224.055	224.055		569.696	569.696		357.272	224.055	569.696	0															0						Linear,1(1)	2.516936779022217	2.516936779022217	2.516936779022217	2.516936779022217	0.0	2.516936779022217	357.272	357.272	224.055	224.055	569.696	569.696	UP	1.0	0.0	0.0	
R-DRE-1483255	PI Metabolism	39	41	1	1	0	0	0	0	1	0	0	17	41	4834	0.86648	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-201556	Signaling by ALK	11	12	1	1	0	1	1	1	1	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-202733	Cell surface interactions at the vascular wall	42	57	2	2	0	2	2	2	2	0	0	17	57	4818	0.81908	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-451927	Interleukin-2 family signaling	10	17	1	1	0	1	1	1	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-512988	Interleukin-3, Interleukin-5 and GM-CSF signaling	18	21	1	1	0	1	1	1	1	0	0	17	21	4854	0.92937	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-912526	Interleukin receptor SHC signaling	7	10	1	1	0	1	1	1	1	0	0	17	10	4865	0.96576	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-373752	Netrin-1 signaling	18	19	1	1	0	1	1	1	1	0	0	17	19	4856	0.93588	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-376172	DSCAM interactions	5	5	1	1	0	1	1	1	1	0	0	17	5	4870	0.98274	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-196807	Nicotinate metabolism	10	16	1	0	0	1	1	0	1	0	0	17	16	4859	0.94574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-197264	Nicotinamide salvaging	6	9	1	0	0	1	1	0	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6806834	Signaling by MET	46	47	2	2	1	1	1	1	2	0	0	17	47	4828	0.84841	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8854214	TBC/RABGAPs	27	28	1	0	0	0	0	0	1	0	0	17	28	4847	0.90688	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8856828	Clathrin-mediated endocytosis	76	84	1	1	1	0	0	0	1	0	0	17	84	4791	0.74459	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2454202	Fc epsilon receptor (FCERI) signaling	34	43	1	1	0	1	1	1	1	0	0	17	43	4832	0.86042	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2871796	FCERI mediated MAPK activation	16	24	1	1	0	1	1	1	1	0	0	17	24	4851	0.91967	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3214847	HATs acetylate histones	25	34	1	0	0	1	1	0	1	0	0	17	34	4841	0.88802	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-111457	Release of apoptotic factors from the mitochondria	3	4	1	1	0	1	1	1	1	0	0	17	4	4871	0.98617	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-111469	SMAC, XIAP-regulated apoptotic response	1	1	1	1	0	1	1	1	1	0	0	17	1	4874	0.99652	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1474290	Collagen formation	30	34	1	1	1	0	0	0	1	0	0	17	34	4841	0.88802	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1650814	Collagen biosynthesis and modifying enzymes	26	30	1	1	1	0	0	0	1	0	0	17	30	4845	0.90055	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-429914	Deadenylation-dependent mRNA decay	28	33	1	1	1	0	0	0	1	0	0	17	33	4842	0.89114	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	10	12	1	1	1	0	0	0	1	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	52	60	1	1	1	0	0	0	1	0	0	17	60	4815	0.81047	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8951664	Neddylation	118	144	6	3	1	4	4	4	6	1	1	16	143	4732	0.91227	0.39876	0.39876	0.69	555190	fbxo31	ENSDARG00000062195		385.381	385.381	385.381		385.381		235.759	235.759	235.759		235.759		629.959	629.959	629.959		629.959						385.381	235.759	629.959	1	0	1	555190	ENSDARG00000062195	385.381	385.381		235.759	235.759		629.959	629.959		385.381	235.759	629.959	0															0						Linear,1(1)	2.2916767597198486	2.2916767597198486	2.2916767597198486	2.2916767597198486	0.0	2.2916767597198486	385.381	385.381	235.759	235.759	629.959	629.959	UP	1.0	0.0	0.0	
R-DRE-157579	Telomere Maintenance	34	45	1	0	0	1	1	0	1	0	0	17	45	4830	0.8544	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73886	Chromosome Maintenance	44	63	1	0	0	1	1	0	1	0	0	17	63	4812	0.80195	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-373080	Class B/2 (Secretin family receptors)	23	38	2	2	1	0	0	0	2	0	0	17	38	4837	0.87565	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-392518	Signal amplification	21	24	1	1	1	0	0	0	1	0	0	17	24	4851	0.91967	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418592	ADP signalling through P2Y purinoceptor 1	17	19	1	1	1	0	0	0	1	0	0	17	19	4856	0.93588	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	38	43	2	2	1	2	2	1	2	0	0	17	43	4832	0.86042	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-72187	mRNA 3'-end processing	32	36	2	1	0	1	1	1	2	0	0	17	36	4839	0.88182	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-72202	Transport of Mature Transcript to Cytoplasm	38	43	2	2	1	2	2	1	2	0	0	17	43	4832	0.86042	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-72203	Processing of Capped Intron-Containing Pre-mRNA	137	157	3	2	1	2	2	1	3	0	0	17	157	4718	0.57381	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9006936	Signaling by TGFB family members	47	55	1	0	0	1	1	1	1	0	0	17	55	4820	0.82487	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-192105	Synthesis of bile acids and bile salts	16	20	1	1	1	1	1	1	1	1	1	16	19	4856	0.99792	0.067381	0.067381	5.0	394148	cyp7a1	ENSDARG00000069018		364.114	364.114	364.114		364.114		226.901	226.901	226.901		226.901		584.304	584.304	584.304		584.304		0.0	364.114			364.114	226.901	584.304	1	0	1	394148	ENSDARG00000069018	364.114	364.114		226.901	226.901		584.304	584.304		364.114	226.901	584.304	0															0						Linear,1(1)	2.3825085163116455	2.3825085163116455	2.3825085163116455	2.3825085163116455	0.0	2.3825085163116455	364.114	364.114	226.901	226.901	584.304	584.304	UP	1.0	0.0	0.0	
R-DRE-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	11	13	1	1	1	1	1	1	1	1	1	16	12	4863	0.99913	0.044299	0.044299	7.69	394148	cyp7a1	ENSDARG00000069018		364.114	364.114	364.114		364.114		226.901	226.901	226.901		226.901		584.304	584.304	584.304		584.304		0.0	364.114			364.114	226.901	584.304	1	0	1	394148	ENSDARG00000069018	364.114	364.114		226.901	226.901		584.304	584.304		364.114	226.901	584.304	0															0						Linear,1(1)	2.3825085163116455	2.3825085163116455	2.3825085163116455	2.3825085163116455	0.0	2.3825085163116455	364.114	364.114	226.901	226.901	584.304	584.304	UP	1.0	0.0	0.0	
R-DRE-194068	Bile acid and bile salt metabolism	17	21	1	1	1	1	1	1	1	1	1	16	20	4855	0.9977	0.070635	0.070635	4.76	394148	cyp7a1	ENSDARG00000069018		364.114	364.114	364.114		364.114		226.901	226.901	226.901		226.901		584.304	584.304	584.304		584.304						364.114	226.901	584.304	1	0	1	394148	ENSDARG00000069018	364.114	364.114		226.901	226.901		584.304	584.304		364.114	226.901	584.304	0															0						Linear,1(1)	2.3825085163116455	2.3825085163116455	2.3825085163116455	2.3825085163116455	0.0	2.3825085163116455	364.114	364.114	226.901	226.901	584.304	584.304	UP	1.0	0.0	0.0	
R-DRE-8957322	Metabolism of steroids	47	62	1	1	1	1	1	1	1	1	1	16	61	4814	0.98098	0.19522	0.19522	1.61	394148	cyp7a1	ENSDARG00000069018		364.114	364.114	364.114		364.114		226.901	226.901	226.901		226.901		584.304	584.304	584.304		584.304						364.114	226.901	584.304	1	0	1	394148	ENSDARG00000069018	364.114	364.114		226.901	226.901		584.304	584.304		364.114	226.901	584.304	0															0						Linear,1(1)	2.3825085163116455	2.3825085163116455	2.3825085163116455	2.3825085163116455	0.0	2.3825085163116455	364.114	364.114	226.901	226.901	584.304	584.304	UP	1.0	0.0	0.0	
R-DRE-5621481	C-type lectin receptors (CLRs)	54	61	1	1	1	1	1	0	1	0	0	17	61	4814	0.80762	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5668541	TNFR2 non-canonical NF-kB pathway	43	59	1	1	0	1	1	1	1	0	0	17	59	4816	0.81333	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	6	11	1	1	0	1	1	1	1	0	0	17	11	4864	0.96239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8980692	RHOA GTPase cycle	72	77	4	3	2	2	2	2	4	1	1	16	76	4799	0.97145	0.23674	0.23674	1.3	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-9013106	RHOC GTPase cycle	39	39	3	3	2	2	2	2	3	1	1	16	38	4837	0.99219	0.12741	0.12741	2.56	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-9013405	RHOD GTPase cycle	27	30	2	2	1	2	2	2	2	1	1	16	29	4846	0.99533	0.099446	0.099446	3.33	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-9013406	RHOQ GTPase cycle	34	36	1	1	0	1	1	1	1	0	0	17	36	4839	0.88182	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013408	RHOG GTPase cycle	39	40	1	1	0	1	1	1	1	0	0	17	40	4835	0.86953	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013409	RHOJ GTPase cycle	31	32	1	1	0	1	1	1	1	0	0	17	32	4843	0.89427	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9696273	RND1 GTPase cycle	30	32	1	1	0	1	1	1	1	0	0	17	32	4843	0.89427	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6791312	TP53 Regulates Transcription of Cell Cycle Genes	23	27	2	2	2	0	0	0	2	0	0	17	27	4848	0.91006	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-140342	Apoptosis induced DNA fragmentation	16	16	2	2	1	1	1	1	2	0	0	17	16	4859	0.94574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2559583	Cellular Senescence	100	112	6	5	2	4	4	3	6	0	0	17	112	4763	0.67409	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	19	19	2	2	1	1	1	1	2	0	0	17	19	4856	0.93588	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2559586	DNA Damage/Telomere Stress Induced Senescence	41	48	4	3	2	2	2	1	4	0	0	17	48	4827	0.84544	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-75153	Apoptotic execution phase	34	34	2	2	1	1	1	1	2	0	0	17	34	4841	0.88802	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-425397	Transport of vitamins, nucleosides, and related molecules	17	23	1	0	0	0	0	0	1	0	0	17	23	4852	0.92289	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-727802	Transport of nucleotide sugars	5	6	1	0	0	0	0	0	1	0	0	17	6	4869	0.97932	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2142845	Hyaluronan metabolism	5	11	1	1	0	1	1	1	1	0	0	17	11	4864	0.96239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-983712	Ion channel transport	58	65	2	1	0	1	1	1	2	0	0	17	65	4810	0.79631	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2173782	Binding and Uptake of Ligands by Scavenger Receptors	15	23	1	0	0	1	1	1	1	0	0	17	23	4852	0.92289	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5690714	CD22 mediated BCR regulation	2	4	1	1	0	1	1	1	1	0	0	17	4	4871	0.98617	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-114508	Effects of PIP2 hydrolysis	11	12	1	1	0	1	1	1	1	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2990846	SUMOylation	103	123	6	4	2	6	6	4	6	1	1	16	122	4753	0.93331	0.35184	0.35184	0.81	386658	ndnl2	ENSDARG00000058212		481.815	481.815	481.815		481.815		270.053	270.053	270.053		270.053		859.632	859.632	859.632		859.632						481.815	270.053	859.632	1	0	1	386658	ENSDARG00000058212	481.815	481.815		270.053	270.053		859.632	859.632		481.815	270.053	859.632	0															0						Linear,1(1)	1.8775469064712524	1.8775469064712524	1.8775469064712524	1.8775469064712524	0.0	1.8775469064712524	481.815	481.815	270.053	270.053	859.632	859.632	UP	1.0	0.0	0.0	
R-DRE-3108232	SUMO E3 ligases SUMOylate target proteins	98	117	5	4	2	5	5	3	5	1	1	16	116	4759	0.93895	0.33781	0.33781	0.85	386658	ndnl2	ENSDARG00000058212		481.815	481.815	481.815		481.815		270.053	270.053	270.053		270.053		859.632	859.632	859.632		859.632						481.815	270.053	859.632	1	0	1	386658	ENSDARG00000058212	481.815	481.815		270.053	270.053		859.632	859.632		481.815	270.053	859.632	0															0						Linear,1(1)	1.8775469064712524	1.8775469064712524	1.8775469064712524	1.8775469064712524	0.0	1.8775469064712524	481.815	481.815	270.053	270.053	859.632	859.632	UP	1.0	0.0	0.0	
R-DRE-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand	24	28	2	2	1	0	0	0	2	0	0	17	28	4847	0.90688	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-383280	Nuclear Receptor transcription pathway	32	37	2	1	0	2	2	1	2	0	0	17	37	4838	0.87873	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4090294	SUMOylation of intracellular receptors	19	22	2	1	0	2	2	1	2	0	0	17	22	4853	0.92612	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5625740	RHO GTPases activate PKNs	37	47	1	0	0	1	1	0	1	0	0	17	47	4828	0.84841	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	22	31	1	0	0	1	1	0	1	0	0	17	31	4844	0.89741	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8856825	Cargo recognition for clathrin-mediated endocytosis	51	58	1	1	1	0	0	0	1	0	0	17	58	4817	0.8162	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9035034	RHOF GTPase cycle	20	22	1	1	0	1	1	1	1	0	0	17	22	4853	0.92612	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-216083	Integrin cell surface interactions	27	30	1	1	1	1	1	0	1	0	0	17	30	4845	0.90055	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3000178	ECM proteoglycans	20	20	1	1	1	0	0	0	1	0	0	17	20	4855	0.93262	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-354192	Integrin signaling	15	15	2	1	0	2	2	2	2	0	0	17	15	4860	0.94905	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins 	8	8	2	1	0	2	2	2	2	0	0	17	8	4867	0.97252	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-372708	p130Cas linkage to MAPK signaling for integrins	8	8	2	1	0	2	2	2	2	0	0	17	8	4867	0.97252	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5674135	MAP2K and MAPK activation	23	24	2	1	0	2	2	2	2	0	0	17	24	4851	0.91967	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-76009	Platelet Aggregation (Plug Formation)	19	21	2	1	0	2	2	2	2	0	0	17	21	4854	0.92937	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8874081	MET activates PTK2 signaling	15	16	1	1	1	0	0	0	1	0	0	17	16	4859	0.94574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8875878	MET promotes cell motility	23	24	2	2	1	1	1	1	2	0	0	17	24	4851	0.91967	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-936837	Ion transport by P-type ATPases	19	20	1	1	0	1	1	1	1	0	0	17	20	4855	0.93262	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-72172	mRNA Splicing	111	127	2	1	0	1	1	1	2	0	0	17	127	4748	0.63897	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9031628	NGF-stimulated transcription	4	5	1	1	0	0	0	0	1	0	0	17	5	4870	0.98274	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-200425	Carnitine metabolism	10	10	1	0	0	1	1	0	1	0	0	17	10	4865	0.96576	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013424	RHOV GTPase cycle	21	21	1	1	0	1	1	1	1	0	0	17	21	4854	0.92937	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-72163	mRNA Splicing - Major Pathway	105	120	2	1	0	1	1	1	2	0	0	17	120	4755	0.65514	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-193704	p75 NTR receptor-mediated signalling	39	47	1	1	0	1	1	1	1	0	0	17	47	4828	0.84841	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4086400	PCP/CE pathway	59	66	1	1	1	0	0	0	1	0	0	17	66	4809	0.7935	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-416482	G alpha (12/13) signalling events	37	45	1	1	1	0	0	0	1	0	0	17	45	4830	0.8544	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1852241	Organelle biogenesis and maintenance	99	121	5	5	3	1	1	1	5	1	1	16	120	4755	0.93521	0.34719	0.34719	0.83	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-2565942	Regulation of PLK1 Activity at G2/M Transition	36	46	4	3	1	1	1	1	4	1	1	16	45	4830	0.98925	0.1486	0.1486	2.17	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-3108214	SUMOylation of DNA damage response and repair proteins	43	52	3	3	2	3	3	2	3	1	1	16	51	4824	0.98639	0.16637	0.16637	1.92	386658	ndnl2	ENSDARG00000058212		481.815	481.815	481.815		481.815		270.053	270.053	270.053		270.053		859.632	859.632	859.632		859.632						481.815	270.053	859.632	1	0	1	386658	ENSDARG00000058212	481.815	481.815		270.053	270.053		859.632	859.632		481.815	270.053	859.632	0															0						Linear,1(1)	1.8775469064712524	1.8775469064712524	1.8775469064712524	1.8775469064712524	0.0	1.8775469064712524	481.815	481.815	270.053	270.053	859.632	859.632	UP	1.0	0.0	0.0	
R-DRE-380259	Loss of Nlp from mitotic centrosomes	32	41	3	3	1	1	1	1	3	1	1	16	40	4835	0.99139	0.13352	0.13352	2.44	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-380270	Recruitment of mitotic centrosome proteins and complexes	36	45	3	3	1	1	1	1	3	1	1	16	44	4831	0.98969	0.1456	0.1456	2.22	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-380284	Loss of proteins required for interphase microtubule organization from the centrosome	32	41	3	3	1	1	1	1	3	1	1	16	40	4835	0.99139	0.13352	0.13352	2.44	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-380287	Centrosome maturation	36	45	3	3	1	1	1	1	3	1	1	16	44	4831	0.98969	0.1456	0.1456	2.22	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-380320	Recruitment of NuMA to mitotic centrosomes	36	45	3	3	1	1	1	1	3	1	1	16	44	4831	0.98969	0.1456	0.1456	2.22	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-453274	Mitotic G2-G2/M phases	88	110	5	4	2	1	1	1	5	1	1	16	109	4766	0.94529	0.32109	0.32109	0.91	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-5617833	Cilium Assembly	79	99	5	5	3	1	1	1	5	1	1	16	98	4777	0.95474	0.294	0.294	1.01	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-5620912	Anchoring of the basal body to the plasma membrane	43	55	3	3	1	1	1	1	3	1	1	16	54	4821	0.98485	0.17513	0.17513	1.82	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-69275	G2/M Transition	87	109	5	4	2	1	1	1	5	1	1	16	108	4767	0.94618	0.31866	0.31866	0.92	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-8854518	AURKA Activation by TPX2	33	42	3	3	1	1	1	1	3	1	1	16	41	4834	0.99098	0.13655	0.13655	2.38	561882	alms1	ENSDARG00000074779		406.866	406.866	406.866		406.866		244.153	244.153	244.153		244.153		678.017	678.017	678.017		678.017						406.866	244.153	678.017	1	0	1	561882	ENSDARG00000074779	406.866	406.866		244.153	244.153		678.017	678.017		406.866	244.153	678.017	0															0						Linear,1(1)	2.087548017501831	2.087548017501831	2.087548017501831	2.087548017501831	0.0	2.087548017501831	406.866	406.866	244.153	244.153	678.017	678.017	UP	1.0	0.0	0.0	
R-DRE-9646399	Aggrephagy	21	24	2	2	1	0	0	0	2	0	0	17	24	4851	0.91967	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1475029	Reversible hydration of carbon dioxide	3	4	1	0	0	1	1	1	1	0	0	17	4	4871	0.98617	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-392170	ADP signalling through P2Y purinoceptor 12	14	17	1	1	1	0	0	0	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-977443	GABA receptor activation	31	40	1	1	1	0	0	0	1	0	0	17	40	4835	0.86953	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-977444	GABA B receptor activation	23	29	1	1	1	0	0	0	1	0	0	17	29	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-991365	Activation of GABAB receptors	23	29	1	1	1	0	0	0	1	0	0	17	29	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3000171	Non-integrin membrane-ECM interactions	8	9	1	1	1	0	0	0	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-201681	TCF dependent signaling in response to WNT	102	127	1	0	0	1	1	0	1	0	0	17	127	4748	0.63897	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-201722	Formation of the beta-catenin:TCF transactivating complex	36	44	1	0	0	1	1	0	1	0	0	17	44	4831	0.8574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9018519	Estrogen-dependent gene expression	56	74	2	0	0	2	2	0	2	0	0	17	74	4801	0.7714	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6811434	COPI-dependent Golgi-to-ER retrograde traffic	51	57	4	3	2	2	2	2	4	1	1	16	56	4819	0.98378	0.18092	0.18092	1.75	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-8856688	Golgi-to-ER retrograde transport	58	64	4	3	2	2	2	2	4	1	1	16	63	4812	0.97981	0.20088	0.20088	1.56	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-983189	Kinesins	26	31	4	3	2	2	2	2	4	1	1	16	30	4845	0.99502	0.10259	0.10259	3.23	323197	racgap1	ENSDARG00000015460		561.995	561.995	561.995		561.995		291.93	291.93	291.93		291.93		1081.9	1081.9	1081.9		1081.9						561.995	291.93	1081.9	1	0	1	323197	ENSDARG00000015460	561.995	561.995		291.93	291.93		1081.9	1081.9		561.995	291.93	1081.9	0															0						Linear,1(1)	3.4197008609771724	3.419700860977173	3.419700860977173	3.419700860977173	0.0	3.419700860977173	561.995	561.995	291.93	291.93	1081.9	1081.9	UP	1.0	0.0	0.0	
R-DRE-877300	Interferon gamma signaling	9	11	1	1	0	1	1	1	1	0	0	17	11	4864	0.96239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-909733	Interferon alpha/beta signaling	5	9	1	1	0	1	1	1	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-913531	Interferon Signaling	19	24	1	1	0	1	1	1	1	0	0	17	24	4851	0.91967	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3215018	Processing and activation of SUMO	9	10	1	0	0	1	1	1	1	0	0	17	10	4865	0.96576	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73884	Base Excision Repair	30	38	1	0	0	1	1	0	1	0	0	17	38	4837	0.87565	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73929	Base-Excision Repair, AP Site Formation	17	24	1	0	0	1	1	0	1	0	0	17	24	4851	0.91967	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-174824	Plasma lipoprotein assembly, remodeling, and clearance	31	33	4	3	1	4	4	3	4	1	1	16	32	4843	0.99437	0.10886	0.10886	3.03	114421	angptl3	ENSDARG00000044365		400.684	400.684	400.684		400.684		241.829	241.829	241.829		241.82899999999998		663.889	663.889	663.889		663.889						400.684	241.829	663.889	1	0	1	114421	ENSDARG00000044365	400.684	400.684		241.829	241.829		663.889	663.889		400.684	241.829	663.889	0															0						Linear,1(1)	1.5623180866241455	1.5623180866241455	1.5623180866241455	1.5623180866241455	0.0	1.5623180866241455	400.684	400.684	241.829	241.829	663.889	663.889	UP	1.0	0.0	0.0	
R-DRE-8964043	Plasma lipoprotein clearance	16	18	1	1	0	1	1	1	1	0	0	17	18	4857	0.93916	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211897	Cytochrome P450 - arranged by substrate type	26	37	2	2	1	2	2	2	2	1	1	16	36	4839	0.99295	0.12127	0.12127	2.7	394148	cyp7a1	ENSDARG00000069018		364.114	364.114	364.114		364.114		226.901	226.901	226.901		226.901		584.304	584.304	584.304		584.304						364.114	226.901	584.304	1	0	1	394148	ENSDARG00000069018	364.114	364.114		226.901	226.901		584.304	584.304		364.114	226.901	584.304	0															0						Linear,1(1)	2.3825085163116455	2.3825085163116455	2.3825085163116455	2.3825085163116455	0.0	2.3825085163116455	364.114	364.114	226.901	226.901	584.304	584.304	UP	1.0	0.0	0.0	
R-DRE-211935	Fatty acids	8	11	1	1	0	1	1	1	1	0	0	17	11	4864	0.96239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211958	Miscellaneous substrates	10	15	1	1	0	1	1	1	1	0	0	17	15	4860	0.94905	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211981	Xenobiotics	13	17	1	1	0	1	1	1	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211999	CYP2E1 reactions	7	10	1	1	0	1	1	1	1	0	0	17	10	4865	0.96576	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9018677	Biosynthesis of DHA-derived SPMs	11	16	1	1	0	1	1	1	1	0	0	17	16	4859	0.94574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9018678	Biosynthesis of specialized proresolving mediators (SPMs)	11	17	1	1	0	1	1	1	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9018682	Biosynthesis of maresins	9	12	1	1	0	1	1	1	1	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9027307	Biosynthesis of maresin-like SPMs	9	12	1	1	0	1	1	1	1	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-432047	Passive transport by Aquaporins	9	9	1	1	0	1	1	1	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-445717	Aquaporin-mediated transport	29	31	2	2	1	1	1	1	2	0	0	17	31	4844	0.89741	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2187338	Visual phototransduction	43	47	3	3	0	2	2	2	3	0	0	17	47	4828	0.84841	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9709957	Sensory Perception	48	71	3	3	0	2	2	2	3	0	0	17	71	4804	0.77962	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-975634	Retinoid metabolism and transport	12	15	1	1	0	0	0	0	1	0	0	17	15	4860	0.94905	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2559580	Oxidative Stress Induced Senescence	51	59	3	2	0	3	3	2	3	0	0	17	59	4816	0.81333	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2559582	Senescence-Associated Secretory Phenotype (SASP)	42	53	2	1	1	1	1	0	2	0	0	17	53	4822	0.8307	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1660661	Sphingolipid de novo biosynthesis	18	27	1	1	0	1	1	1	1	0	0	17	27	4848	0.91006	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-428157	Sphingolipid metabolism	36	50	2	2	1	2	2	2	2	1	1	16	49	4826	0.98737	0.16049	0.16049	2.0	559072	gba	ENSDARG00000076058		555.131	555.131	555.131		555.131		290.263	290.263	290.263		290.26300000000003		1061.69	1061.69	1061.69		1061.69						555.131	290.263	1061.69	1	0	1	559072	ENSDARG00000076058	555.131	555.131		290.263	290.263		1061.69	1061.69		555.131	290.263	1061.69	0															0						Linear,1(1)	6.696079254150391	6.696079254150391	6.696079254150391	6.696079254150391	0.0	6.696079254150391	555.131	555.131	290.263	290.263	1061.69	1061.69	UP	1.0	0.0	0.0	
R-DRE-2299718	Condensation of Prophase Chromosomes	28	36	2	1	0	2	2	1	2	0	0	17	36	4839	0.88182	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68875	Mitotic Prophase	55	64	5	4	2	4	4	2	5	0	0	17	64	4811	0.79912	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5669034	TNFs bind their physiological receptors	4	12	1	1	0	1	1	1	1	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211000	Gene Silencing by RNA	51	63	2	1	1	2	2	0	2	0	0	17	63	4812	0.80195	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-212165	Epigenetic regulation of gene expression	50	61	1	0	0	1	1	0	1	0	0	17	61	4814	0.80762	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-212300	PRC2 methylates histones and DNA	31	39	1	0	0	1	1	0	1	0	0	17	39	4836	0.87259	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3214815	HDACs deacetylate histones	31	40	1	0	0	1	1	0	1	0	0	17	40	4835	0.86953	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3214858	RMTs methylate histone arginines	28	37	2	0	0	1	1	0	2	0	0	17	37	4838	0.87873	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-427359	SIRT1 negatively regulates rRNA expression	22	30	1	0	0	1	1	0	1	0	0	17	30	4845	0.90055	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5250913	Positive epigenetic regulation of rRNA expression	38	49	1	0	0	1	1	0	1	0	0	17	49	4826	0.84247	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5250924	B-WICH complex positively regulates rRNA expression	38	49	1	0	0	1	1	0	1	0	0	17	49	4826	0.84247	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5250941	Negative epigenetic regulation of rRNA expression	22	30	1	0	0	1	1	0	1	0	0	17	30	4845	0.90055	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5578749	Transcriptional regulation by small RNAs	45	57	2	1	1	2	2	0	2	0	0	17	57	4818	0.81908	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73728	RNA Polymerase I Promoter Opening	23	31	1	0	0	1	1	0	1	0	0	17	31	4844	0.89741	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73772	RNA Polymerase I Promoter Escape	36	51	1	0	0	1	1	0	1	0	0	17	51	4824	0.83656	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73854	RNA Polymerase I Promoter Clearance	45	60	1	0	0	1	1	0	1	0	0	17	60	4815	0.81047	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73864	RNA Polymerase I Transcription	46	61	1	0	0	1	1	0	1	0	0	17	61	4814	0.80762	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	33	44	2	0	0	1	1	0	2	0	0	17	44	4831	0.8574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-429947	Deadenylation of mRNA	17	17	1	1	1	0	0	0	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	13	14	1	1	1	0	0	0	1	0	0	17	14	4861	0.95237	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-110330	Recognition and association of DNA glycosylase with site containing an affected purine	13	20	1	0	0	1	1	0	1	0	0	17	20	4855	0.93262	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-110331	Cleavage of the damaged purine	14	21	1	0	0	1	1	0	1	0	0	17	21	4854	0.92937	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-606279	Deposition of new CENPA-containing nucleosomes at the centromere	20	33	1	0	0	1	1	0	1	0	0	17	33	4842	0.89114	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73927	Depurination	14	21	1	0	0	1	1	0	1	0	0	17	21	4854	0.92937	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-774815	Nucleosome assembly	20	33	1	0	0	1	1	0	1	0	0	17	33	4842	0.89114	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9670095	Inhibition of DNA recombination at telomere	15	21	1	0	0	1	1	0	1	0	0	17	21	4854	0.92937	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4551638	SUMOylation of chromatin organization proteins	29	30	2	2	1	2	2	1	2	0	0	17	30	4845	0.90055	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5620924	Intraflagellar transport	23	29	3	3	2	0	0	0	3	0	0	17	29	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-70171	Glycolysis	22	22	2	2	1	2	2	2	2	1	1	16	21	4854	0.99748	0.073878	0.073878	4.55	564852	pfkfb2b	ENSDARG00000002037		357.267	357.267	357.267		357.267		223.934	223.934	223.934		223.93399999999997		569.99	569.99	569.99		569.99						357.267	223.934	569.99	1	0	1	564852	ENSDARG00000002037	357.267	357.267		223.934	223.934		569.99	569.99		357.267	223.934	569.99	0															0						Linear,1(1)	3.200669288635254	3.200669288635254	3.200669288635254	3.200669288635254	0.0	3.200669288635254	357.267	357.267	223.934	223.934	569.99	569.99	UP	1.0	0.0	0.0	
R-DRE-70326	Glucose metabolism	33	34	3	2	1	3	3	3	3	1	1	16	33	4842	0.99403	0.11198	0.11198	2.94	564852	pfkfb2b	ENSDARG00000002037		357.267	357.267	357.267		357.267		223.934	223.934	223.934		223.93399999999997		569.99	569.99	569.99		569.99						357.267	223.934	569.99	1	0	1	564852	ENSDARG00000002037	357.267	357.267		223.934	223.934		569.99	569.99		357.267	223.934	569.99	0															0						Linear,1(1)	3.200669288635254	3.200669288635254	3.200669288635254	3.200669288635254	0.0	3.200669288635254	357.267	357.267	223.934	223.934	569.99	569.99	UP	1.0	0.0	0.0	
R-DRE-5368287	Mitochondrial translation	44	55	1	0	0	1	1	1	1	0	0	17	55	4820	0.82487	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5389840	Mitochondrial translation elongation	42	53	1	0	0	1	1	1	1	0	0	17	53	4822	0.8307	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5419276	Mitochondrial translation termination	43	54	1	0	0	1	1	1	1	0	0	17	54	4821	0.82778	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2995410	Nuclear Envelope (NE) Reassembly	34	35	1	1	1	1	1	0	1	0	0	17	35	4840	0.88491	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9615933	Postmitotic nuclear pore complex (NPC) reformation	15	15	1	1	1	1	1	0	1	0	0	17	15	4860	0.94905	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-912694	Regulation of IFNA signaling	3	6	1	1	0	1	1	1	1	0	0	17	6	4869	0.97932	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8866427	VLDLR internalisation and degradation	8	9	1	1	0	1	1	1	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-211976	Endogenous sterols	10	16	1	1	1	1	1	1	1	1	1	16	15	4860	0.99867	0.054256	0.054256	6.25	394148	cyp7a1	ENSDARG00000069018		364.114	364.114	364.114		364.114		226.901	226.901	226.901		226.901		584.304	584.304	584.304		584.304		0.0	364.114			364.114	226.901	584.304	1	0	1	394148	ENSDARG00000069018	364.114	364.114		226.901	226.901		584.304	584.304		364.114	226.901	584.304	0															0						Linear,1(1)	2.3825085163116455	2.3825085163116455	2.3825085163116455	2.3825085163116455	0.0	2.3825085163116455	364.114	364.114	226.901	226.901	584.304	584.304	UP	1.0	0.0	0.0	
R-DRE-162710	Synthesis of glycosylphosphatidylinositol (GPI)	7	14	1	1	0	0	0	0	1	0	0	17	14	4861	0.95237	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-163125	Post-translational modification: synthesis of GPI-anchored proteins	7	16	1	1	0	0	0	0	1	0	0	17	16	4859	0.94574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8943724	Regulation of PTEN gene transcription	23	25	1	1	0	1	1	1	1	0	0	17	25	4850	0.91645	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-399719	Trafficking of AMPA receptors	9	9	1	1	1	0	0	0	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-399721	Glutamate binding, activation of AMPA receptors and synaptic plasticity	9	9	1	1	1	0	0	0	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-416993	Trafficking of GluR2-containing AMPA receptors	9	9	1	1	1	0	0	0	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5099900	WNT5A-dependent internalization of FZD4	9	9	1	1	1	0	0	0	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-171306	Packaging Of Telomere Ends	13	19	1	0	0	1	1	0	1	0	0	17	19	4856	0.93588	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5689603	UCH proteinases	50	61	1	0	0	1	1	0	1	0	0	17	61	4814	0.80762	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5689901	Metalloprotease DUBs	15	20	2	0	0	2	2	1	2	0	0	17	20	4855	0.93262	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-112308	Presynaptic depolarization and calcium channel opening	7	7	1	1	1	0	0	0	1	0	0	17	7	4868	0.97591	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3238698	WNT ligand biogenesis and trafficking	10	20	1	1	0	1	1	1	1	0	0	17	20	4855	0.93262	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5173214	O-glycosylation of TSR domain-containing proteins	13	16	1	1	0	1	1	1	1	0	0	17	16	4859	0.94574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	15	17	1	1	0	1	1	1	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-450341	Activation of the AP-1 family of transcription factors	6	6	1	1	0	1	1	1	1	0	0	17	6	4869	0.97932	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	35	41	1	1	1	0	0	0	1	0	0	17	41	4834	0.86648	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5213460	RIPK1-mediated regulated necrosis	13	16	2	2	1	2	2	2	2	1	1	16	15	4860	0.99867	0.054256	0.054256	6.25	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61		0.0	639.862			639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-5675482	Regulation of necroptotic cell death	13	16	2	2	1	2	2	2	2	1	1	16	15	4860	0.99867	0.054256	0.054256	6.25	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61		0.0	639.862			639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-3232142	SUMOylation of ubiquitinylation proteins	22	27	1	1	1	1	1	0	1	0	0	17	27	4848	0.91006	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8875555	MET activates RAP1 and RAC1	9	10	1	1	0	1	1	1	1	0	0	17	10	4865	0.96576	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3899300	SUMOylation of transcription cofactors	32	34	1	1	0	1	1	1	1	0	0	17	34	4841	0.88802	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-193648	NRAGE signals death through JNK	22	25	1	1	0	1	1	1	1	0	0	17	25	4850	0.91645	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-204998	Cell death signalling via NRAGE, NRIF and NADE	30	34	1	1	0	1	1	1	1	0	0	17	34	4841	0.88802	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-187577	SCF(Skp2)-mediated degradation of p27/p21	37	44	1	1	1	0	0	0	1	0	0	17	44	4831	0.8574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	6	7	1	1	1	0	0	0	1	0	0	17	7	4868	0.97591	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69563	p53-Dependent G1 DNA Damage Response	38	44	1	1	1	0	0	0	1	0	0	17	44	4831	0.8574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69580	p53-Dependent G1/S DNA damage checkpoint	38	44	1	1	1	0	0	0	1	0	0	17	44	4831	0.8574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69615	G1/S DNA Damage Checkpoints	39	46	1	1	1	0	0	0	1	0	0	17	46	4829	0.8514	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9616222	Transcriptional regulation of granulopoiesis	4	4	1	1	1	0	0	0	1	0	0	17	4	4871	0.98617	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418346	Platelet homeostasis	37	43	3	3	1	1	1	1	3	0	0	17	43	4832	0.86042	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1442490	Collagen degradation	12	16	1	1	1	0	0	0	1	0	0	17	16	4859	0.94574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-140534	Caspase activation via Death Receptors in the presence of ligand	6	9	1	1	0	1	1	1	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3371378	Regulation by c-FLIP	6	9	1	1	0	1	1	1	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5218900	CASP8 activity is inhibited	6	9	1	1	0	1	1	1	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5357769	Caspase activation via extrinsic apoptotic signalling pathway	9	12	1	1	0	1	1	1	1	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69416	Dimerization of procaspase-8	6	9	1	1	0	1	1	1	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-75158	TRAIL  signaling	4	5	1	1	0	1	1	1	1	0	0	17	5	4870	0.98274	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8878159	Transcriptional regulation by RUNX3	50	54	1	1	1	1	1	1	1	1	1	16	53	4822	0.98537	0.17222	0.17222	1.85	30445	brd2a	ENSDARG00000022280		9.60763	9.60763	9.60763		9.60763		2.15135	2.15135	2.15135		2.15135		42.9063	42.9063	42.9063		42.9063						9.60763	2.15135	42.9063	1	0	1	30445	ENSDARG00000022280	9.60763	9.60763		2.15135	2.15135		42.9063	42.9063		9.60763	2.15135	42.9063	0															0						Hill,1(1)	1.9332624673843384	1.9332624673843384	1.9332624673843384	1.9332624673843384	0.0	1.9332624673843384	9.60763	9.60763	2.15135	2.15135	42.9063	42.9063	UP	1.0	0.0	0.0	
R-DRE-1433557	Signaling by SCF-KIT	19	23	1	1	0	1	1	1	1	0	0	17	23	4852	0.92289	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1433559	Regulation of KIT signaling	10	11	1	1	0	1	1	1	1	0	0	17	11	4864	0.96239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013407	RHOH GTPase cycle	18	20	1	1	0	1	1	1	1	0	0	17	20	4855	0.93262	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-156584	Cytosolic sulfonation of small molecules	14	16	2	1	0	1	1	1	2	0	0	17	16	4859	0.94574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6807878	COPI-mediated anterograde transport	49	51	2	2	1	0	0	0	2	0	0	17	51	4824	0.83656	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2465910	MASTL Facilitates Mitotic Progression	2	2	1	1	0	1	1	1	1	0	0	17	2	4873	0.99306	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69306	DNA Replication	73	87	1	0	0	1	1	1	1	0	0	17	87	4788	0.73671	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2022090	Assembly of collagen fibrils and other multimeric structures	16	18	1	1	1	0	0	0	1	0	0	17	18	4857	0.93916	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1660662	Glycosphingolipid metabolism	18	23	1	1	1	1	1	1	1	1	1	16	22	4853	0.99724	0.077111	0.077111	4.35	559072	gba	ENSDARG00000076058		555.131	555.131	555.131		555.131		290.263	290.263	290.263		290.26300000000003		1061.69	1061.69	1061.69		1061.69						555.131	290.263	1061.69	1	0	1	559072	ENSDARG00000076058	555.131	555.131		290.263	290.263		1061.69	1061.69		555.131	290.263	1061.69	0															0						Linear,1(1)	6.696079254150391	6.696079254150391	6.696079254150391	6.696079254150391	0.0	6.696079254150391	555.131	555.131	290.263	290.263	1061.69	1061.69	UP	1.0	0.0	0.0	
R-DRE-204174	Regulation of pyruvate dehydrogenase (PDH) complex	11	12	1	1	0	1	1	1	1	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-70268	Pyruvate metabolism	18	20	1	1	0	1	1	1	1	0	0	17	20	4855	0.93262	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	35	38	1	1	0	1	1	1	1	0	0	17	38	4837	0.87565	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-937039	IRAK1 recruits IKK complex	12	13	1	1	1	1	1	1	1	1	1	16	12	4863	0.99913	0.044299	0.044299	7.69	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61		0.0	639.862			639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	12	13	1	1	1	1	1	1	1	1	1	16	12	4863	0.99913	0.044299	0.044299	7.69	558420	peli1b	ENSDARG00000044083		639.862	639.862	639.862		639.862		308.159	308.159	308.159		308.159		1328.61	1328.61	1328.61		1328.61		0.0	639.862			639.862	308.159	1328.61	0	1	0															1	558420	ENSDARG00000044083	639.862	639.862		308.159	308.159		1328.61	1328.61		639.862	308.159	1328.61	0						Linear,1(1)	1.6919761896133423	1.6919761896133423	1.6919761896133423	1.6919761896133423	0.0	1.6919761896133423	639.862	639.862	308.159	308.159	1328.61	1328.61	DOWN	0.0	1.0	0.0	
R-DRE-1296041	Activation of G protein gated Potassium channels	16	22	1	1	1	0	0	0	1	0	0	17	22	4853	0.92612	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1296059	G protein gated Potassium channels	16	22	1	1	1	0	0	0	1	0	0	17	22	4853	0.92612	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1296065	Inwardly rectifying K+ channels	19	28	1	1	1	0	0	0	1	0	0	17	28	4847	0.90688	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	16	22	1	1	1	0	0	0	1	0	0	17	22	4853	0.92612	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-201451	Signaling by BMP	15	17	1	0	0	1	1	1	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1168372	Downstream signaling events of B Cell Receptor (BCR)	41	46	1	1	1	0	0	0	1	0	0	17	46	4829	0.8514	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-456926	Thrombin signalling through proteinase activated receptors (PARs)	21	26	1	1	1	0	0	0	1	0	0	17	26	4849	0.91325	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-176187	Activation of ATR in response to replication stress	15	22	1	0	0	1	1	1	1	0	0	17	22	4853	0.92612	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68962	Activation of the pre-replicative complex	18	22	1	0	0	1	1	1	1	0	0	17	22	4853	0.92612	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69002	DNA Replication Pre-Initiation	51	60	1	0	0	1	1	1	1	0	0	17	60	4815	0.81047	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2672351	Stimuli-sensing channels	27	33	1	0	0	0	0	0	1	0	0	17	33	4842	0.89114	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-432040	Vasopressin regulates renal water homeostasis via Aquaporins	25	27	2	2	1	1	1	1	2	0	0	17	27	4848	0.91006	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5621575	CD209 (DC-SIGN) signaling	6	6	1	1	1	1	1	0	1	0	0	17	6	4869	0.97932	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013420	RHOU GTPase cycle	24	25	1	1	0	1	1	1	1	0	0	17	25	4850	0.91645	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1169091	Activation of NF-kappaB in B cells	33	38	1	1	1	0	0	0	1	0	0	17	38	4837	0.87565	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8963889	Assembly of active LPL and LIPC lipase complexes	2	2	1	1	1	1	1	1	1	1	1	16	1	4874	0.99999	0.0069388	0.0069388	50.0	114421	angptl3	ENSDARG00000044365		400.684	400.684	400.684		400.684		241.829	241.829	241.829		241.82899999999998		663.889	663.889	663.889		663.889		0.0	400.684	0.0	400.684	400.684	241.829	663.889	1	0	1	114421	ENSDARG00000044365	400.684	400.684		241.829	241.829		663.889	663.889		400.684	241.829	663.889	0															0						Linear,1(1)	1.5623180866241455	1.5623180866241455	1.5623180866241455	1.5623180866241455	0.0	1.5623180866241455	400.684	400.684	241.829	241.829	663.889	663.889	UP	1.0	0.0	0.0	
R-DRE-8963899	Plasma lipoprotein remodeling	8	8	2	2	1	2	2	2	2	1	1	16	7	4868	0.99969	0.027484	0.027484	12.5	114421	angptl3	ENSDARG00000044365		400.684	400.684	400.684		400.684		241.829	241.829	241.829		241.82899999999998		663.889	663.889	663.889		663.889		0.0	400.684	0.0	400.684	400.684	241.829	663.889	1	0	1	114421	ENSDARG00000044365	400.684	400.684		241.829	241.829		663.889	663.889		400.684	241.829	663.889	0															0						Linear,1(1)	1.5623180866241455	1.5623180866241455	1.5623180866241455	1.5623180866241455	0.0	1.5623180866241455	400.684	400.684	241.829	241.829	663.889	663.889	UP	1.0	0.0	0.0	
R-DRE-8953750	Transcriptional Regulation by E2F6	16	19	1	1	0	1	1	1	1	0	0	17	19	4856	0.93588	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77289	Mitochondrial Fatty Acid Beta-Oxidation	13	16	1	1	0	1	1	1	1	0	0	17	16	4859	0.94574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1237044	Erythrocytes take up carbon dioxide and release oxygen	8	11	1	0	0	1	1	1	1	0	0	17	11	4864	0.96239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1247673	Erythrocytes take up oxygen and release carbon dioxide	6	9	1	0	0	1	1	1	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1480926	O2/CO2 exchange in erythrocytes	8	11	1	0	0	1	1	1	1	0	0	17	11	4864	0.96239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2514853	Condensation of Prometaphase Chromosomes	5	7	1	1	0	1	1	1	1	0	0	17	7	4868	0.97591	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2514856	The phototransduction cascade	20	20	1	1	0	1	1	1	1	0	0	17	20	4855	0.93262	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2514859	Inactivation, recovery and regulation of the phototransduction cascade	19	19	1	1	0	1	1	1	1	0	0	17	19	4856	0.93588	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4570464	SUMOylation of RNA binding proteins	25	26	2	2	1	2	2	1	2	0	0	17	26	4849	0.91325	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	22	26	1	1	0	1	1	1	1	0	0	17	26	4849	0.91325	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-390466	Chaperonin-mediated protein folding	23	26	1	1	1	0	0	0	1	0	0	17	26	4849	0.91325	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-391251	Protein folding	23	26	1	1	1	0	0	0	1	0	0	17	26	4849	0.91325	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	23	26	1	1	1	0	0	0	1	0	0	17	26	4849	0.91325	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	3	3	1	0	0	1	1	1	1	0	0	17	3	4872	0.98961	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	4	5	1	0	0	1	1	1	1	0	0	17	5	4870	0.98274	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-379716	Cytosolic tRNA aminoacylation	1	1	1	1	1	1	1	1	1	1	1	16	0	4875	1.0	0.0034751	0.0034751	100.0	402961	ppa2	ENSDARG00000009685		527.114	527.114	527.114		527.114		282.787	282.787	282.787		282.787		982.538	982.538	982.538		982.538		0.0	527.114	0.0	527.114	527.114	282.787	982.538	1	0	1	402961	ENSDARG00000009685	527.114	527.114		282.787	282.787		982.538	982.538		527.114	282.787	982.538	0															0						Linear,1(1)	3.0292406082153316	3.029240608215332	3.029240608215332	3.029240608215332	0.0	3.029240608215332	527.114	527.114	282.787	282.787	982.538	982.538	UP	1.0	0.0	0.0	
R-DRE-379724	tRNA Aminoacylation	1	1	1	1	1	1	1	1	1	1	1	16	0	4875	1.0	0.0034751	0.0034751	100.0	402961	ppa2	ENSDARG00000009685		527.114	527.114	527.114		527.114		282.787	282.787	282.787		282.787		982.538	982.538	982.538		982.538		0.0	527.114	0.0	527.114	527.114	282.787	982.538	1	0	1	402961	ENSDARG00000009685	527.114	527.114		282.787	282.787		982.538	982.538		527.114	282.787	982.538	0															0						Linear,1(1)	3.0292406082153316	3.029240608215332	3.029240608215332	3.029240608215332	0.0	3.029240608215332	527.114	527.114	282.787	282.787	982.538	982.538	UP	1.0	0.0	0.0	
R-DRE-2142850	Hyaluronan biosynthesis and export	1	3	1	1	0	1	1	1	1	0	0	17	3	4872	0.98961	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9024446	NR1H2 and NR1H3-mediated signaling	7	7	1	1	0	1	1	1	1	0	0	17	7	4868	0.97591	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9029569	NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux	7	7	1	1	0	1	1	1	1	0	0	17	7	4868	0.97591	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9623433	NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis	4	4	1	1	0	1	1	1	1	0	0	17	4	4871	0.98617	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8963898	Plasma lipoprotein assembly	10	10	1	0	0	1	1	0	1	0	0	17	10	4865	0.96576	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	4	4	1	1	0	1	1	1	1	0	0	17	4	4871	0.98617	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	3	3	1	1	0	1	1	1	1	0	0	17	3	4872	0.98961	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	3	3	1	1	0	1	1	1	1	0	0	17	3	4872	0.98961	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-169893	Prolonged ERK activation events	12	12	1	1	0	1	1	1	1	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-170968	Frs2-mediated activation	11	11	1	1	0	1	1	1	1	0	0	17	11	4864	0.96239	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-187687	Signalling to ERKs	17	17	1	1	0	1	1	1	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8963896	HDL assembly	6	6	1	0	0	1	1	0	1	0	0	17	6	4869	0.97932	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-70263	Gluconeogenesis	21	22	1	0	0	1	1	1	1	0	0	17	22	4853	0.92612	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9634600	Regulation of glycolysis by fructose 2,6-bisphosphate metabolism	4	4	1	1	1	1	1	1	1	1	1	16	3	4872	0.99993	0.013832	0.013832	25.0	564852	pfkfb2b	ENSDARG00000002037		357.267	357.267	357.267		357.267		223.934	223.934	223.934		223.93399999999997		569.99	569.99	569.99		569.99		0.0	357.267	0.0	357.267	357.267	223.934	569.99	1	0	1	564852	ENSDARG00000002037	357.267	357.267		223.934	223.934		569.99	569.99		357.267	223.934	569.99	0															0						Linear,1(1)	3.200669288635254	3.200669288635254	3.200669288635254	3.200669288635254	0.0	3.200669288635254	357.267	357.267	223.934	223.934	569.99	569.99	UP	1.0	0.0	0.0	
R-DRE-202040	G-protein activation	15	19	1	1	1	0	0	0	1	0	0	17	19	4856	0.93588	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	20	25	2	2	1	1	1	1	2	0	0	17	25	4850	0.91645	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-400042	Adrenaline,noradrenaline inhibits insulin secretion	14	17	1	1	1	0	0	0	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418597	G alpha (z) signalling events	20	23	1	1	1	0	0	0	1	0	0	17	23	4852	0.92289	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-420092	Glucagon-type ligand receptors	16	23	2	2	1	0	0	0	2	0	0	17	23	4852	0.92289	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-428930	Thromboxane signalling through TP receptor	15	17	1	1	1	0	0	0	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8964616	G beta:gamma signalling through CDC42	13	15	1	1	1	0	0	0	1	0	0	17	15	4860	0.94905	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2187335	The retinoid cycle in cones (daylight vision)	5	6	1	1	0	1	1	1	1	0	0	17	6	4869	0.97932	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-419771	Opsins	5	8	1	1	0	1	1	1	1	0	0	17	8	4867	0.97252	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-392517	Rap1 signalling	10	10	1	1	0	1	1	1	1	0	0	17	10	4865	0.96576	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1660516	Synthesis of PIPs at the early endosome membrane	6	6	1	1	0	0	0	0	1	0	0	17	6	4869	0.97932	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	6	7	1	1	1	1	1	1	1	1	1	16	6	4869	0.99976	0.024088	0.024088	14.29	394148	cyp7a1	ENSDARG00000069018		364.114	364.114	364.114		364.114		226.901	226.901	226.901		226.901		584.304	584.304	584.304		584.304		0.0	364.114	0.0	364.114	364.114	226.901	584.304	1	0	1	394148	ENSDARG00000069018	364.114	364.114		226.901	226.901		584.304	584.304		364.114	226.901	584.304	0															0						Linear,1(1)	2.3825085163116455	2.3825085163116455	2.3825085163116455	2.3825085163116455	0.0	2.3825085163116455	364.114	364.114	226.901	226.901	584.304	584.304	UP	1.0	0.0	0.0	
R-DRE-70635	Urea cycle	3	6	1	1	0	1	1	1	1	0	0	17	6	4869	0.97932	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8948216	Collagen chain trimerization	13	16	1	1	1	0	0	0	1	0	0	17	16	4859	0.94574	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-159227	Transport of the SLBP independent Mature mRNA	16	17	1	1	1	1	1	0	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-159230	Transport of the SLBP Dependant Mature mRNA	16	17	1	1	1	1	1	0	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-159231	Transport of Mature mRNA Derived from an Intronless Transcript	16	17	1	1	1	1	1	0	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	16	17	1	1	1	1	1	0	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-70221	Glycogen breakdown (glycogenolysis)	9	9	1	1	0	0	0	0	1	0	0	17	9	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8982491	Glycogen metabolism	12	12	2	1	0	1	1	1	2	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4085377	SUMOylation of SUMOylation proteins	21	22	1	1	1	1	1	0	1	0	0	17	22	4853	0.92612	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2980766	Nuclear Envelope Breakdown	20	21	2	2	2	1	1	0	2	0	0	17	21	4854	0.92937	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3301854	Nuclear Pore Complex (NPC) Disassembly	16	17	1	1	1	1	1	0	1	0	0	17	17	4858	0.94245	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-4615885	SUMOylation of DNA replication proteins	28	29	1	1	1	1	1	0	1	0	0	17	29	4846	0.90371	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-196783	Coenzyme A biosynthesis	2	3	1	1	0	0	0	0	1	0	0	17	3	4872	0.98961	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-199220	Vitamin B5 (pantothenate) metabolism	3	5	1	1	0	0	0	0	1	0	0	17	5	4870	0.98274	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	6	6	1	1	1	1	1	1	1	1	1	16	5	4870	0.99983	0.020681	0.020681	16.67	30071	tbx5a	ENSDARG00000024894		639.248	639.248	639.248		639.248		307.869	307.869	307.869		307.869		1327.31	1327.31	1327.31		1327.31		0.0	639.248	0.0	639.248	639.248	307.869	1327.31	1	0	1	30071	ENSDARG00000024894	639.248	639.248		307.869	307.869		1327.31	1327.31		639.248	307.869	1327.31	0															0						Linear,1(1)	5.529194355010986	5.529194355010986	5.529194355010986	5.529194355010986	0.0	5.529194355010986	639.248	639.248	307.869	307.869	1327.31	1327.31	UP	1.0	0.0	0.0	
R-DRE-8964058	HDL remodeling	3	3	1	1	0	1	1	1	1	0	0	17	3	4872	0.98961	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-392851	Prostacyclin signalling through prostacyclin receptor	13	15	1	1	1	0	0	0	1	0	0	17	15	4860	0.94905	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8964315	G beta:gamma signalling through BTK	11	14	1	1	1	0	0	0	1	0	0	17	14	4861	0.95237	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9007892	Interleukin-38 signaling	2	2	1	1	0	1	1	1	1	0	0	17	2	4873	0.99306	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5668599	RHO GTPases Activate NADPH Oxidases	8	13	1	1	1	0	0	0	1	0	0	17	13	4862	0.9557	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8951936	RUNX3 regulates p14-ARF	5	5	1	1	1	1	1	1	1	1	1	16	4	4871	0.99989	0.017262	0.017262	20.0	30445	brd2a	ENSDARG00000022280		9.60763	9.60763	9.60763		9.60763		2.15135	2.15135	2.15135		2.15135		42.9063	42.9063	42.9063		42.9063		0.0	9.60763	0.0	9.60763	9.60763	2.15135	42.9063	1	0	1	30445	ENSDARG00000022280	9.60763	9.60763		2.15135	2.15135		42.9063	42.9063		9.60763	2.15135	42.9063	0															0						Hill,1(1)	1.9332624673843384	1.9332624673843384	1.9332624673843384	1.9332624673843384	0.0	1.9332624673843384	9.60763	9.60763	2.15135	2.15135	42.9063	42.9063	UP	1.0	0.0	0.0	
R-DRE-4419969	Depolymerisation of the Nuclear Lamina	5	5	1	1	1	0	0	0	1	0	0	17	5	4870	0.98274	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-174362	Transport and synthesis of PAPS	6	6	1	0	0	0	0	0	1	0	0	17	6	4869	0.97932	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-170984	ARMS-mediated activation	4	4	1	1	0	1	1	1	1	0	0	17	4	4871	0.98617	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-114516	Disinhibition of SNARE formation	2	2	1	1	1	0	0	0	1	0	0	17	2	4873	0.99306	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-139910	Activation of BMF and translocation to mitochondria	3	3	1	1	0	1	1	1	1	0	0	17	3	4872	0.98961	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3000480	Scavenging by Class A Receptors	5	6	1	0	0	1	1	1	1	0	0	17	6	4869	0.97932	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6803544	Ion influx/efflux at host-pathogen interface	2	2	1	1	0	0	0	0	1	0	0	17	2	4873	0.99306	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-432142	Platelet sensitization by LDL	12	12	2	2	0	1	1	1	2	0	0	17	12	4863	0.95904	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-210990	PECAM1 interactions	6	7	1	1	0	1	1	1	1	0	0	17	7	4868	0.97591	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-70370	Galactose catabolism	3	4	1	1	0	0	0	0	1	0	0	17	4	4871	0.98617	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-166187	Mitochondrial Uncoupling	3	3	1	0	0	1	1	1	1	0	0	17	3	4872	0.98961	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3322077	Glycogen synthesis	5	5	2	1	0	1	1	1	2	0	0	17	5	4870	0.98274	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-167826	The fatty acid cycling model	2	2	1	0	0	1	1	1	1	0	0	17	2	4873	0.99306	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-167827	The proton buffering model	2	2	1	0	0	1	1	1	1	0	0	17	2	4873	0.99306	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-71737	Pyrophosphate hydrolysis	1	1	1	1	1	1	1	1	1	1	1	16	0	4875	1.0	0.0034751	0.0034751	100.0	402961	ppa2	ENSDARG00000009685		527.114	527.114	527.114		527.114		282.787	282.787	282.787		282.787		982.538	982.538	982.538		982.538		0.0	527.114	0.0	527.114	527.114	282.787	982.538	1	0	1	402961	ENSDARG00000009685	527.114	527.114		282.787	282.787		982.538	982.538		527.114	282.787	982.538	0															0						Linear,1(1)	3.0292406082153316	3.029240608215332	3.029240608215332	3.029240608215332	0.0	3.029240608215332	527.114	527.114	282.787	282.787	982.538	982.538	UP	1.0	0.0	0.0	
